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Abstract
In the frame of therapeutic drug monitoring and personalized medicine, point-of-care systems
(POCs) that can help overcome long waiting times for results and costly procedures of clinical
tests are highly desirable. At present, the detection of low-molecular-weight molecules with
portable systems remains a challenge. In addition, measurements in serum have always
been more complicated with respect to buffer solutions due to the occurrence of non-specific
binding.
This thesis presents a portable transmission-localized SPR (T-LSPR)-based setup that is in-
tended to work as a POC for the detection of small molecules in serum. As a biorecognition
element, a selected DNA aptamer specific to tobramycin (467 Da) has been used to func-
tionalize a gold nanoislands (NIs) fluorine-doped tin oxide (FTO) covered glass that acts as a
biosensor.
As a proof of concept, real-time detection in TE buffer was performed by monitoring concen-
trations down to 0.5 µM and enabling the observation of association and dissociation phases.
The extracted parameters match those obtained with a high-end commercial SPR system.
Concentrations of tobramycin in undiluted serum down to 10 µM were measured. The
interesting effect of the serum is that it masks the association kinetics of the tobramycin to the
DNA aptamer. The quantification of the captured tobramycin is calculated at the beginning
of the dissociation phase and leads to a linear calibration curve for the concentrations in the
clinical range tested. The reason why the binding of tobramycin is hindered by the serum
remains under investigation.
The T-LSPR system employs low-cost, off-the-shelf components that make it possible to scale
down the system to a palm size. The CMOS image sensor, employed as a light detector, forced
the choice of the NIs to have resonance in the visible spectrum in order to match the sensitivity
of the light detector. Despite the low sensitivity of the NIs FTO-coated glass slides, justified
by the irregularity in size and pattern of the NIs and of the FTO substrate, the NIs exhibit
extremely high stability in high-ionic solutions, standing continuous regeneration cycles
without altering their sensing properties and without denaturation of the DNA aptamer on
their surface.
An algorithm for the extraction of the plasmon peak location of the resonance was developed.
To increase the speed of data elaboration and to allow the real-time display of the results, hue
was studied and used as an alternative parameter for plasmonic evaluation.
Keywords: localized surface plasmon resonance, nanoislands, label-free, small molecule,
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iv
Sommario
La medicina personalizzata necessita del monitoraggio terapeutico dei farmaci, per il quale
i sistemi Point-of-Care (POC) sono altamente desiderabili per ovviare alla lunga attesa dei
risultati e ridurre i costi dei test clinici. Tuttavia, ad oggi la rilevazione di molecole a basso
peso molecolare, come la maggior parte dei farmaci attualmente in uso, con sistemi portatili
rimane ancora difficoltosa. In particolare, misure condotte direttamente in siero sanguigno
sono ancora più complicate rispetto alle soluzioni tampone a causa delle interferenze da
legami aspecifici Questo lavoro presenta un sistema portatile POC, basato sul fenomeno
della risonanza plasmonica di superficie in transmissione (T-LSPR), per la quantificazione di
farmaci in siero.
Come elemento di riconoscimento del biosensore, un aptamero a base di DNA specifico per la
molecola modello tobramicina (un antibiotico dal peso molecolare di 467 Da) è stato utilizzato
per funzionalizzare delle nanoisole d’oro (NIs) depositate su vetro ricoperto di ossido di stagno
fluorurato (FTO).
Il sistema T-LSPR ha mostrato che misurazioni di concentrazioni fino a 0,5 µM in tampone
sono possibili in tempo reale, permettendo quindi di osservare le fasi di associazione e dis-
sociazione. I parametri di cinetica di legame estratti corrispondono a quelli ottenuti con un
sistema di risonanza plasmonica di superficie commerciale.
Concentrazioni di tobramicina fino a 10 µM sono state misurate con il sistema T-LSPR in
siero non diluito. Nonostante il siero mascheri la cinetica di associazione della tobramicina
all’aptamero, la quantificazione della tobramicina catturata è calcolabile all’inizio della fase di
dissociazione, generando una curva di calibrazione lineare per le concentrazioni nel range
clinico testato. Il motivo per cui il fenomeno di associazione sia mascherato dal siero è ancora
oggetto di studio.
Il sistema T-LSPR utilizza componenti standard a basso costo che permettono di ridurre
notevolmente le dimensioni del sistema. Il sensore di immagine CMOS, impiegato per deter-
minare le variazioni del plasmone, impone l’utilizzo di NIs con risonanza nello spettro del
visibile. Le NIs hanno una sensibilità minore rispetto a strutture regolari che viene però com-
pensata da un’elevata stabilità in soluzioni ad elevate concentrazioni ioniche, consentendo
cicli di rigenerazione senza alterazione delle proprietà di rilevamento ne’ rilascio dell’aptamero
sulla loro superficie.
E’ stato sviluppato un algoritmo per l’estrazione della posizione del picco di risonanza plas-
monica. Al fine di aumentare la velocità di elaborazione dei dati e per consentire la visual-
izzazione in tempo reale dei risultati, la tinta è stata studiata e utilizzata come parametro
v
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sostitutivo per la valutazione del picco di risonanza.
Parole chiave: risonanza plasmonica di superficie, nanoisole, piccole molecole, point-of-care,
aptameri a DNA.
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Introduction
In terms of clinical treatment, dose adjustment that is precisely tailored to the patients allows
for more efficient healing and reduces side effects. It is crucial to follow the drug concentration
in patients’ blood quite frequently (that is, at different time-points) in order to assess the
personalized pharmacokinetics and pharmacodynamics relative to the drug in use, and thus
to extrapolate dosage corrections.
Drug concentration monitoring is currently performed mainly in highly specialized labo-
ratories, leading to long waiting times for results and costly procedures. In particular, low-
molecular-weight drugs are mainly measured with mass spectrometry techniques.
Accordingly, there is a need for automated and compact analytical systems combining multiple
functions that allow for potentially better therapy and increased autonomy of patients. The
need for those systems, known as point-of-care systems (POCs), is steadily increasing because
clinical analytical facilities are crowded and expensive, and moving treatments outside allows
for in-situ diagnosis and more personalized approaches [2].
For common targets such as glucose or pregnancy tests, there are already portable systems
available; however, the detection of small molecules (<kDa) remains a challenge. The miniatur-
ization and integration of the experimental setup is not always possible and it depends on the
principle of detection employed [3]. Among other detection techniques, such as imaging, flow
cytometry, immunoassays, electrochemical detection, magnetic detection [4], POCs based
on optical detection are preferred because they are relatively immune to electromagnetic
interference and they permit multiple measurements in an array configuration [5, 6].
During the last few decades, antibodies have been the preferred way to detect medical analytes.
However, only a few antibodies are available for small drugs detection and their production
is often costly and suffers from high batch variability. Recently, aptamers have become
increasingly popular in small-molecule detection, as they can be directly synthesized and
modified while showing similar high affinity binding than their specific analytes. Moreover,
aptamers offer higher thermal and chemical stability (especially DNA-aptamers) with respect
to antibodies, which makes them particularly suitable for biosensing applications based on
molecular recognition.
Currently, low-molecular-weight molecules are often detected by means of competitive assays,
1
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sandwich assays or conjugated analyte molecules [7, 8, 9]. In the literature, mainly fluores-
cence [10] and electrochemical detection [11, 12, 13] systems have been used to characterize
the kinetics of small molecules. For instance, the colorimetric detection of Xia et al.[14] em-
ploys aptamers to detect a small molecule (cocaine) through inhibition assay via conjugated
polyelectrolyte. Optical [15, 16, 17] and electrochemical [18, 19, 20, 21] detection systems
allow for measurements in pure or diluted serum only for target molecules above the KDa
range (mainly proteins and cancer biomarkers).
Despite their sensitivity, the extra manipulation of the molecules can alter their behavior and
recognition properties. Label-free optical biosensors measure the change in the refractive
index (RI) in the proximity of the sensor’s surface, without any manipulation of the molecules,
leaving them and their properties unaltered. However, low-molecular-weight drugs are very
difficult to monitor because of the low RI change they produce.
Therefore, a system that is suitable for being scaled down as a portable device while reducing
the complexity of the system itself, of the biosensor, and of the sample preparation would be
desirable.
The choice of the biosensor represents one of the most critical features. In the literature,
a variety of plasmonic nanostructures with high sensitivity have been presented. However,
the major concern for biosensing application is the stability of the nanostructures when
put in contact with solvents and under continuous flow. To overcome this limitation, the
nanostructures are often passivated with protective layers or deposited on the substrate via an
adhesion layer to improve their stability.
A portable label-free optical detection system based on transmission-localized surface plas-
mon resonance (T-LSPR) employing gold nanoislands deposited on a fluorine-doped tin oxide
covered glass is presented here. This system is able to measure the binding kinetics of a
small molecule, tobramycin, via direct assay to a selected DNA aptamer in undiluted serum.
Because of the label-free measurement system and the direct assay, sample preparation and
elaboration are reduced at minimum.
2
1 Motivation and state of the art
The objectives of the thesis are to design and develop an optical detection system suitable as
a point-of-care (POC) device and to investigate its performance for real-time monitoring of
biomolecular interaction. The study includes design, optimization and characterization of
such a device and real-time measurements performed in an undiluted serum environment.
The system is based on localized surface plasmon resonance (LSPR) and is intended to be
compact and simple. In addition, thanks to the non-connected pattern of the biosensor’s
nanostructures, it can perform array measurements.
This thesis is developed in the frame of the Nano-Tera Program, which was addressed to
develop therapeutic monitoring of drug concentrations in blood samples and drug dosage
adjustments tailored to the patient. At present, specific blood tests are performed only in
highly specialized laboratories, often leading to costly procedures and a long waiting time for
results.
1.1 Definition of personalized medicine
Nowadays, the need for early detection of disease and rapid time to results for clinical tests
have increased interest in developing new diagnostic tools and medical care support. Current
medicine develops and administers drugs to patients to treat illness and non-physiological
conditions. However, since drugs generally tend to target as many patients as possible, the
same drug can be differently tolerated and can have different effects on the healing process.
Personalized medicine consists of using the patient’s genetic profile and clinical data to select
a personal therapy or medication and administer it at the proper dosage. The administration
of a drug needs to be dosed such that its concentration stays within a therapeutic range.
The therapeutic range of a drug defines the concentration at which the patient has the clinical
benefits, while reducing the adverse effects. The size of the range is determined by the minimal
effective concentration and maximal toxic concentration of the drug. If the drug concentration
in blood is below the desired level, there will be no pharmacological effect. On the contrary,
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excessive dosage can lead to an adverse response and side effects (Figure 1.1).
The time window in which the drug concentration stays in the therapeutic range is the duration
of action of the drug. Patients are given multiple doses to stay within the therapeutic range for
the duration of the treatment. After several constant dosages at constant intervals it reaches a
level called steady state, which is when the amount of drug accumulated in the body is equal
to the amount of drug the body expels. The therapeutic windows vary among the population,
depending on age, sex, metabolism, and health. Therefore, it is important to control the
dosage amount and frequency in a drug therapy.
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Figure 1.1: Representation of a drug’s therapeutic range (left) and steady-state level reached
after constant, repeated drug administration (right).
In personalized medicine, pharmacokinetics and pharmacodynamics are used for dose mon-
itoring and adjustment. In particular, pharmacokinetics evaluates the drug concentration
in blood, which is drug dose versus drug concentration. Pharmacodynamics refers to the
concentration of biomarkers in blood, which is drug concentration versus drug effect.
At present, specific tests are mainly done in a few highly specialized laboratories, leading
to a long wait for results. These tests are costly and require trained personnel. Therefore,
there is a need for automated, compact analytical systems that combine the ability to observe
the presence of a molecule in a sample and adjust its dose accordingly. These functions are
coupled with communication capabilities to be connected with doctors and pharmacokinetic
parameter databases for further refinement in dosage adjustment procedures [2].
Point-of-care (POC) systems satisfy these criteria.
1.2 Relevance and impact of point-of-care systems in the health-
care field
Health monitoring systems combining multiple functions represent a potential for better
therapy and increased patient autonomy. The need for those systems, referred to as POCs, is
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steadily increasing because clinical analytical facilities are crowded and expensive. Moving
treatments outside the hospital allows for in-situ diagnosis and more personalized approaches.
POCs are rapidly expanding because of the more readily available technology to produce them
and their portability and ease of use.
There are already examples of POCs currently used in daily life. Some applications require
sporadic tests (allergy, pregnancy), while others may require multiple monitoring (as for
example glucose blood). In order to develop and implement on a large-scale, POCs need to be
miniaturized and integrated, while providing autonomy, user-friendliness, high throughput,
and automated reagent delivery.
The integration of microfluidic modules for delivering the reagents assures minimal contam-
ination and only a small amount of sample volume needed, with consequent reduction of
reagent consumption, leading to overall cost reduction [22].
The growing interest in POCs is evidenced by the broad applications already available, such as
a POC performing ELISA tests for HIV diagnosis in Rwanda [23], a mobile phone-mounted light
microscope [24], a POC mounted on smart phone for evaluating and correcting misaligned
eyes [25], and many other examples [26, 27, 28, 29, 30].
Nevertheless, miniaturization and integration of the experimental setup is not always possible.
It depends on the detection method that is used [3]. Among other detection techniques, such
as imaging, flow cytometry, immunoassays, electrochemical detection and magnetic detection
[4], POCs based on optical detection are preferred because they are relatively immune to elec-
tromagnetic interference and they permit multiple measurements in an array configuration
[5, 6]. An overview of optical detection techniques is given in the next paragraph.
1.3 Concept of optical detection and affinity biosensors
POCs require a biosensor, in which the biomolecular event takes place. Biosensors based on
optical affinity are devices consisting of a biorecognition element for molecules with affinity
toward specific target molecules and an optical transducer that translates the binding event
into an output signal (Figure 1.2) [31].
As schematically represented in Figure 1.2, the biorecognition element is typically covalently
bound to the sensor surface, while the analyte to be detected is delivered to the surface. In
cases of affinity matches between the biorecognition element and the delivered analyte, a
change in the optical signal is detected.
Biosensors are classified according to their analytical capability (the ability to monitor a
single or several parameters on the same device), reusability (if they are disposable or support
multiple uses), and assay format (if they are label-based or label-free).
Label-based affinity biosensors require labeling the target molecule under study with a dye
5
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Figure 1.2: Schematic of an optical transducer hosting a biorecognition element on its surface
(left) that changes its optical parameters upon analyte binding (right).
or a fluorescent marker. This step is time-consuming, costly, and could alter the targets’
recognition properties. However, this method is widely used because of its high sensitivity
at low concentrations and high throughput [32, 33, 34, 35, 36, 37, 38]. On the other hand,
label-free biosensors do not require any manipulation of the molecules prior to the binding
experiment, leaving the molecules and their properties unaltered.
Examples of applied optical detection principles that measure changes in the refractive index
(RI) in proximity of the surface of the sensor include interferometric sensors and sensors based
on spectroscopy of guided waves (grating coupler, resonant mirror, SPR sensors) [39, 5, 40].
The main features of label-free biosensors are the ability to perform direct assays, or detect the
analyte in one-step, and real-time measurements with continuous monitoring of the binding
events. This work focuses on localized SPR detection based sensors.
The performance of a biosensor can be expressed in terms of:
• Sensitivity: The entity of output signal variation signal in relation to the binding event
occurring on the sensor surface
• Specificity: The ability of the biorecognition element to recognize the molecule of
interest and discriminate it from other molecules in the solution
• Limit of detection (LOD): The minimum detectable quantity of analyte that can be
discriminated from the noise of the measurement
Effective biosensors detect the target in physiologic concentrations and do so without any ad-
ditional processing of the target biological fluid. They operate with small volumes and control
multiple parameters. Together with the implementation of a module for signal processing,
data transmission, powering and end-user interface, they can contribute to the increasing use
of POCs for personalized medicine.
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1.4 Molecules and assays
The quantification procedure to detect the activity or the amount of a substance is referred to
as biological assay. The type of assay adopted in SPR optical detection systems depends on
the molecules under study. The main applications are the study of biomolecule interaction
(antigen-antibody, protein-protein, protein-DNA, DNA hybridization) association and dissoci-
ation rates, specificity, detection and identification of chemical and biological analytes (drugs,
hormones, toxins, bacterial pathogens) [6].
The choice of the assay type is an essential part of the detection system. Most frequently used
assay formats that produce a measurable signal are:
• Direct detection: Employed for medium- and large-size analytes
• Sandwich assay: Used for small- and medium-size analytes at small concentrations
• Indirect detection (competition, inhibition): Employed for small analytes at very low
concentrations
The direct assay consists of a one-step recognition event of a probe immobilized on the
surface that specifically binds the analyte in solution. The produced change in RI is directly
proportional to the amount of analyte bound to the probe. The binding interaction kinetics
has an exponential time dependence. As the interaction progresses, there are fewer available
sites, until equilibrium between the association and dissociation processes is reached. The
time needed to reach equilibrium depends on the concentration of the analyte, leading to a
faster interaction for a larger amount of analyte.
The sandwich-assay format consists of two steps. In the first step, the analyte is delivered to
the surface and bound to the biorecognition element on surface. In the second step, another
molecule, specific to the previously bound analyte, is delivered to the surface and recognizes
the analyte, thus increasing the total number of molecules on surface and increasing the
change of RI.
In the competition assay, the surface is covered with the biorecognition element. The sample
solution delivered to the surface contains a mixture of the analyte and an analyte conjugate.
The difference in signal between a reference solution that contains only conjugated ana-
lyte and the sample solution indicates the amount of analyte in the sample. High analyte
concentrations in the sample result in low signals.
The inhibition assay requires the binding of the analyte on the surface. The sample solution
that contains the analyte is mixed with biorecognition elements in excess. The biorecognition
element binds both to the analyte in solution and to the analyte previously bound to the
surface. The difference in signal between a blank solution that does not contain the ana-
lyte and the sample solution indicates the amount of analyte in the sample. High analyte
concentrations result in low signals.
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1.5 Kinetics of biomolecular interactions
Quantitative information about the kinetic association and dissociation constants can be
extracted from the observation of a binding interaction in real time. This provides information
regarding complex formation and stability.
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Figure 1.3: The profile of the SPR response versus time gives an indication of the association
and dissociation steps of the binding interaction. Figure adapted from Biacore GE.
The majority of the binding interactions are bi-molecular (or two molecules), the analyte A,
and its capturing probe B, that react together to form the complex AB. The relationship can be
written as:
A+B KON−−−*)−−
KOFF
AB (1.1)
The association (KON ) and dissociation (KOFF ) rates determine the rates of the complex
formation and breakdown.
The Langmuir kinetic model is based on four assumptions:
• The surface of the adsorbent is uniform
• Adsorbed molecules do not interact
• All adsorptions occur with the same mechanism
8
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• Only a monolayer is obtained at the maximum adsorption
The total amount of captured analytes increases until there are no longer free capturing probes
(saturation coverage) or it is not possible to further increase the target density.
At equilibrium:
KOFF
KON
= [AB ]
[A][B ]
=KD (1.2)
in which the square brackets indicate the concentrations of A and B.
The equilibrium constant KD indicates the strength of the binding between A and B in terms
of how easy it is to separate the complex AB. Analyte concentrations must be accurately known
to determine correct association rate constants. When high concentrations of A and B are
required to form AB, KD is high, indicating a low strength of the binding. On the contrary, a
small KD indicates a strong binding.
Depending on the type of interaction, the experimental conditions need to be optimized in
terms of:
• surface density
• analyte concentration
• flow rate
The flow rate is particularly important for the mass transport effect. In order to bind to the
ligand, the analyte in solution must be transported from the bulk of the solution to the sensor’s
surface. The analyte transportation rate to the surface depends on the dimensions of the
flow cell and the diffusion properties of the analyte. Under laminar flow conditions, it is
proportional to the cube root of the flow rate. If the rate of transport is much faster than
the association rate between analyte and ligand, the analyte/ligand binding is determined
by the kinetics constants. If the mass transport is much lower than the association rate, the
analyte/ligand binding is limited by the rate of the analyte transport, and the binding kinetic
information is lost or only partially available. Optimal assay conditions are high flow rates and
low surface-binding capacity.
1.6 Aptamers
The ability to detect small drug molecules has always been a challenge, due to the low molecu-
lar weight and the small change in the refractive index they cause, often leading to competitive
assays, sandwich assays, or other combinations [8, 7, 9]. Aptamers are oligonucleotide se-
quences that bind to a specific target molecule. The characteristics of aptamers make them
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particularly attractive in diagnostic and therapeutic applications. They also represent a new
topic of interest in biosensing systems [21, 12, 41, 10, 11, 42, 43].
During the last decades, antibodies have been the preferred way to detect analytes. However,
aptamers are steadily conquering more space in small molecule detection, and they proved to
be suitable for applications based on molecular recognition. One of the great advantages of
aptamers is that they can be directly synthesized and modified to specifically recognize any
target molecule with high affinity and specificity [44].
Aptamers are selected through a process called systematic evolution of ligands by exponen-
tial enrichment (SELEX) [45]. The SELEX process is an in-vitro technique for selecting and
amplifying oligonucleotides libraries. The process starts with a random sequence library of
chemically synthesized DNA containing approximately 1014 to 1015 individual molecules. The
complexity of the library depends on the number of randomized nucleotide positions.
The iterative process starts with the incubation of a random DNA sequence library with
the target of interest in a certain buffer at a certain temperature. During this step, a small
fraction of the random sequences will interact with the target. These sequences are physically
separated from the rest of the library. The selected sequences are then amplified to enrich
their number in the library and used to repeat another cycle of selection and subsequent
amplification. After several repetitions of these cycles of selection/amplification, the affinity
saturation is reached and the selected sequences are cloned and sequenced to obtain the
sequence information of each member.
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Figure 1.4: SELEX process: 1) Oligos pool (initially a library of randomized oligos). 2) Binding
to the support via the immobilized analyte. 3) Elution via change in the buffer. 4) Amplification
of the eluted oligos via polymerase chain reaction.
The great interest in aptamers comes from the fact that their properties can be changed
on demand, such as to obtain aptamers that work in non-physiological buffers or at non-
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physiological temperatures. Aptamers are very stable and can stand long-term storage, but
they can denaturate. However, this is a reversible process, and they can be regenerated in few
minutes. The SELEX process guarantees high accuracy and reproducibility in the chemical
synthesis for producing aptamers, as only small variations are expected from batch to batch
of production. Affinity and specificity are the most important characteristics in a diagnostic
assay, as it relies on the affinity and strength of the aptamer-target interaction [46].
The present work focuses on relevant clinical and diagnostic tests involving the detection of
small molecules drugs. We studied the behavior of a small molecule drug, Tobramycin, that is
an antibiotic of 467 Da used to treat lung infections. A variety of selected DNA aptamers to
specifically recognize tobramycin, have been created and studied in our laboratory [47].
1.7 Summary and thesis organization
This thesis is organized as follows.
This chapter discusses the importance of a POC system and the main requirements related
to the healthcare field, together with reviewing some of the fundamentals of biomolecules
interaction and surface detection. The second chapter gives an overview of the analytical
platforms based on SPR, the commercial existing systems, and the progresses of the research.
The third chapter introduces the principles of SPR-based detection, discriminating between
propagating and localized plasmons. In particular, it presents the features related to biosens-
ing. Chapter Four includes the fabrication of the plasmonic nanostructures for the biosensor
chip and the characterization tests of their stability and repeatability. Chapter Five presents
the first prototype of the transmission-localized SPR-based setup. It explains the principle of
the discrete light system employed, and the extraction and reconstruction of the plasmonic
information. Chapter Six describes the optimized, current version of the setup, featuring a
CMOS camera for parallel detection. It includes the adaptation to the current version of the
previously mentioned algorithm, and introduces and validates the hue for a faster evaluation
of the real-time response of the system to biomolecular interactions. In addition, the chapter
presents a characterization of the biosensor’s bulk refractive index sensitivity. Chapter Seven
shows the experiments conducted with the transmission-LSPR setup. The detection of a low
molecular-mass drug, tobramycin, is performed in different matrices, including undiluted
serum.
Several results presented in this thesis have been described by the author in [1, 48].
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2 SPR-based analytical platforms
SPR has been widely studied and is a stable, established technology for recognizing binding
events. The surface plasmon phenomenon was first observed in 1902 by R.W. Wood and then
characterized by Kretchmann, Otto and Raether in 1968 [31]. Liedberg first employed a SPR
setup for biosensing purposes in 1983 [49]. Since then, the field has rapidly developed thanks
to advancements in immobilization techniques and optical measurement approaches [50].
In particular, thanks to improved solutions for immobilizing receptors on the metal surface
and coating techniques, previous limitations due to adsorption of non-specific molecules and
reduced receptor activity have been overcome.
2.1 SPR for biosensing
Nowadays, SPR-based detection systems represent a well-established, commercialized tech-
nology. SPR is a label-free technique that allows the observation of real-time kinetics for
binding processes. SPR is a very sensitive, powerful method for detecting biomolecular bind-
ing of different species, such as proteins, oligonucleotides, and viruses [51]. One of the main
reasons for its robust development is the versatility of SPR-based sensors. In principle, they
can detect any analyte, as long as a biorecognition element specific to the analyte exists.
Because they are based on RI changes in the proximity of the surface, analytes do not have to
exhibit any particular features, such as fluorescence or adsorption and scattering bands, as
their mass should be enough to cause a detectable change in RI.
SPR sensors are sensitive to changes of the RI in the proximity of the surface, independently
from what is causing this change. In principle, any molecule can lead to a RI change, therefore
SPR sensors cannot discriminate between different molecules. In addition, changes in RI could
come from interfering effects, or changes in RI not caused by the analyte, such as non-specific
binding or background RI variations due to sample temperature and composition fluctuations.
Therefore, the specificity of SPR detection systems is assured by the biorecognition element.
The biorecognition element should specifically recognize only the analyte of interest and
prevent non-specific binding to other molecules with similar structures to the analyte under
13
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study.
2.1.1 Measurement schemes
Surface plasmon waves modify their propagation constant according to the bulk and the
surface RI at a metal dielectric interface (see Chapter 3). Most techniques detect changes in
the light reflected by a thin metal layer. This is the case with the prism-coupled attenuated
total reflection method (ATR), the fiber SPR, the waveguide SPR, the grating-coupled SPR, and
the magneto-optic [52, 53].
SPR sensors are classified as angle-, wavelength-, intensity-, phase-, or polarization-modulation-
based, depending on which characteristic is measured (Figure 2.1) [54, 55].
Figure 2.1: SPR sensor based on angular modulation (top left), polarization modulation (top
right), wavelength modulation (bottom left), and intensity modulation (bottom right).
• In SPR sensors with angular modulation, the coupling strength between the excitation
light and the surface plasmon at a fixed wavelength and multiple angles of incidence
of the exciting light is measured, and the angle of incidence yielding to the strongest
coupling (dip in the reflected light) is determined.
• In SPR sensors with wavelength modulation, the coupling strength of the exciting light
and the plasmon is measured at a fixed angle of incidence and multiple wavelengths,
and the wavelength yielding the strongest coupling is determined.
• In SPR sensors based on intensity modulation, the exciting light is at a fixed wavelength
and a fixed angle of incidence, and the changes in intensity of the light interacting with
the plasmon are measured.
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• In SPR sensors based on phase modulation, the shift in phase of the exciting light
coupling with the surface plasmons are measured at a fixed wavelength and a fixed
angle of incidence.
• In SPR sensors based on polarization modulation, changes in the polarization of the
light coupling with the surface plasmons are measured at a fixed wavelength and a fixed
angle of incidence.
2.2 Application areas
Many optical SPR setups have been proposed [50]. So far, SPR-based systems cover a wide
range of applications, such as proteins, antibodies, drugs, and DNA strands. The widespread
use of SPR instrumentation comes from the improvements in monitoring multiple sites in
parallel, functionalization for high-density biochips, microfluidics for delivery of biomolecules
to the sensor surface, functionalization for specific molecular coatings, sample preparation,
and the analyte extraction device.
SPR development targets two specific areas of application: Laboratory platforms for high-
throughput screening and high sensitivity; and mobile platforms for in situ detection.
2.2.1 Laboratory platforms
Commercial SPR systems are generally based on the traditional prism-coupled SPR con-
figuration, which is based on angular spectroscopy, wavelength spectroscopy, or intensity
modulation methods [56].
The traditional biosensing approach consists of simultaneously measuring two sensing chan-
nels, one with the biorecognition element specific to the analyte under study (signal channel)
and one with no specificity (reference channel). At least two sensing channels are needed to
reference for interfering effects that could lead to a false evaluation of the signal. Increasing
the number of channels in a SPR system can increase the number of parallel interactions that
can be monitored at the same time.
Techniques based on SPR detection require rather complex optical systems with limited
parallelism. The main limitations of those systems are that they are costly, bulky, require
trained personnel, and are mainly designed for use in the lab.
At present, the highest number of different sensing sites on standard SPR has been achieved
on the Biacore 4000 [57], which features 16 sensing sites divided over four channels. SPIRIT,
from Seattle Sensor Systems [58], based on SPREETA sensing chips [59], features four SPR
detectors with triplicate measurement and 12 channels. SR7000DC SPR system, from Reichert
Technologies [60], can perform SPR in combination with electrochemistry, fluorescence,
photochemistry, mass spectrometry, and liquid chromatography. Many other SPR systems
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can be found in [61, 50].
Figure 2.2: Examples of commercial platforms based on SPR detection.
To scale up the number of simultaneous sensing areas per experiment, imaging SPR (iSPR)
systems have been developed. The iSPR measures the spatial refractive index changes on a
surface on which an array of biomolecules has been immobilized. It relies on the use of CMOS
or CCD image sensors [62, 63, 64, 65, 66, 67, 68, 69, 70]. Commercially available systems, such
as SPRi-PlexII™ from Horiba (up to 400 biomolecular interactions) [71], or IBIS MX96 (2x48
spots) provide monitoring of several hundred of independent biomolecular interactions [72].
Such systems are equipped with sophisticated optics, so are rather bulky and expensive.
2.2.2 Mobile platforms
The interest in scaling down the systems and making them compact and portable as a POC is
demonstrated by the large number of instruments available: Spreeta from Texas Instruments
[73], SPRmicro from K-MAC [74], and other systems from companies such as Horiba, Sensia,
Toto, and Xuzhou Shengpu (Figure 2.3) [75]. They employ LEDs (TI Spreeta) or lasers (e.g.,
BiochipAnalyzer, SPRnano) as excitation sources and offer up to eight channels (SPRnano).
While the portable iSPR from K-MAC, based on intensity interrogation and featuring 2 CCD,
weights 30 kg, Möbius Advanced Technology offers a handheld SPR platform. Such small-scale
devices usually do not rely on laser sources, but employ LEDs to excite the SPR.
Research on portable SPR-based systems is very active, as in the case of C. E. Furlong’s group,
who presented a system with 24 parallel sensing areas [59], and the group of Homola, which
proposed different SPR setups. One of their systems is based on angular interrogation that
employs a gold-coated diffraction grating to achieve very high sensing resolution (3x10−7
refractive index unit (RIU)) [76], with 10 parallel channels on a disposable cartridge [77].
Another example by the same group is a portable six-channel SPR system based on a special
diffraction grating called a surface plasmon coupler and disperser [78].
A recent review [79] highlighted the most significant contributions in the field of photonics and
lab-on-a-chip. Efforts continue to make systems compact, portable, and possibly integrated.
Scaling down is possible only by avoiding bulky, moving elements, which most commercial
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systems have.
However, further scaling down of SPR-based systems is limited by the difficulties in scaling the
optical excitation system. This is why LSPR-based systems are being heavily investigated as an
alternative to the classical propagating SPR-based methods [80, 81, 82, 83].
Figure 2.3: Examples of commercially available portable platforms based on SPR detection.
2.3 Localized SPR-based platforms
Pushed by the need to reduce the dimensions of SPR optical systems, metallic nanoparticles
supporting LSPR have been investigated. In principle, LSPR allows for increasing the spatial
resolution of a biosensor, as the non-connected pattern of the nanoparticles impedes the
propagation of the plasmon along the surface [84].
Although LSPR sensors are one to two orders of magnitude less sensitive than propagating
SPR [85, 86], they dramatically reduce the complexity and bulk of the optical instrumentation.
However the fabrication of the sensors supporting nanostructures for LSPR can be more
expensive.
The intense research on the sensing nanostructures made the production costs of the nanofab-
rication process constantly drop. As the sensitivity of LSPR systems greatly depends on the
characteristics in size, geometry, materials and interparticle spacing [87, 88, 89], research
mainly focused on identifying the optimum configuration to achieve the best sensitivity. In
this frame, a great variety of structures exhibiting LSPR have been exploited, including metallic
nanoparticles, metal nanopatterns exhibiting a LSPR, and novel materials of greater sensitivity
[90, 91, 92, 52, 93, 94].
Pushed by the need for POC bio-analytical systems, previous works have reported electronic-
based compact implementations of reflectance-based systems for LSPR. Nevertheless, these
reflectance-based setups still require specific optical elements that are difficult to realize on
an integrated system. Neuzil et al. [7] presented a palm-sized biodetection system featuring
four LEDs and a photodiode collecting the light reflected from the sensor surface. The system
has been tested with different RI solutions.
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2.4 Transmission LSPR
The LSPR phenomenon can be observed either in reflectance, as with standard propagating
SPR, or in transmission configuration (T-LSPR). Clearly, a transmission approach is particu-
larly suitable for developing compact, or even integrated, measurement setups, which only
require alignment among light source, sample, and detector. The transmission configuration
may greatly facilitate the development of miniaturized, highly parallel, fully integrated SPR
systems. In contrast, in a reflectance-based system, moving elements are needed to observe,
for example, the changes in the reflectance angle of the light used to excite the sample.
In particular, the principle of T-LSPR has been extensively studied in the works of the Ru-
binstein group since 2000. T-LSPR has characterized molecular binding events, such as
biotin-streptavidin, on discontinued metal layers on inert transparent substrates [95, 96, 97].
Moreover, Hutter and Pileni [98] reported detecting DNA hybridization on a layer of gold
nanoparticles of 2.5 nm on glass.
2.5 Research on LSPR as biosensors in POC systems
In recent years, interest shifted from creating the most sensitive structures [99, 100, 101, 102,
103, 104] to practicality and real-world applications. Reliability and long life of the sensor
are the main requirements for POC systems [105]. The implementation of LSPR biosensors
with a liquid sample-handling interface that operate with small detection volumes in normal
incidence condition allowed for development of simple, miniaturized instrumentation.
Malic et al. presented a system with microfluidic channels integrated with blazed nanograting
structures into thermoplastics substrates [106]. The system was tested with different con-
centrations of glycerin in water and CD44 glicoprotein at clinically relevant concentrations.
Despite the high sensitivity structures and their integration with the microfluidics, they used
a spectrophotometer for transmission detection that limited the biosensor throughput to
sequential measurements. However, it is planned to implement a CCD camera to perform
multiplexed SPR imaging spectroscopy.
Another example of integration of microfluidics with T-LSPR gold nanoparticle structures was
presented by the Borghs group [107]. This system addresses the detection of transmittance
changes at a single wavelength of biotin/anti-biotin recognition experiments, rather than
observing the plasmon peak shift.
Gallegos et al. [108] provides another integration example, in which a label free biodetection
of protein and antibody is performed by a module containing optical components directly
connected to the CMOS camera of a smart phone that acted as a spectrophotometer by
measuring the transmission spectrum of the photonic crystal biosensor.
Recently, systems based on Extraordinary Optical Transmission (EOT) have been presented
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[109, 110, 111, 112, 113]. EOT systems give a plasmonic response that is more stable and
highly reproducible, thanks to array nanostructures surrounded by planar gold, such as
nanoholes, nanocavities, nanoslits, or nanogratings arrays [114, 69, 115, 116]. In this case,
surface plasmon oscillations can be either propagating or localized surface plasmons, but the
nanoholes simplify the detection system by transmittance configuration.
An example of an EOT-based system is presented by the Altug group. They employed direct
coupling of perpendicularly incident light to the plasmonic excitations through nanohole
arrays on thick metal films and image on a CMOS camera. The nanohole array is very highly
sensitive to RI changes. However, the system has only been tested with biomolecules in dry
conditions. In addition, fabricating the nanostructures based on e-beam lithography requires
cost-intensive, time-consuming clean-room processes [111].
S. H. Oh’s group gives another example of an integrated system [117] that employs EOT
on a gold nanohole array integrated with an ITO electrode, which concurrently acts as a
nanoplasmonic sensor and as a gradient-force generator for dielectrophoresis studies. The
same group presented a system featuring 50 channels in parallel with microfluidics [70] that
combined EOT with iSPR. Despite the high parallelism reached, it was a rather complicated
system that employed a high resolution imaging spectrophotometer and a CCD camera that
required precise alignment.
The presented research works are indicative examples of the variety of integrated structures
that can be found. In some cases, the detection systems represent a proof of concept before
the realization of a stand-alone system. In other cases, the systems are rather complicated or
complex fabrication processes are needed. This thesis examines the possibility of a transmis-
sion LSPR setup scaled down in a simple, low-cost configuration, due to the flexibility allowed
by the choice of the nanostructures, as discussed in the next chapter.
2.6 Sensing of small molecules in buffer and serum
Small molecule detection with a label-free optical system has always been challenging, due to
the low molecular weight and their associated small refractive index change. They are often
detected by means of competitive assays, sandwich assays, or conjugated analyte molecules
[7, 8, 9].
In literature, fluorescence [10] and electrochemical detection [118, 11, 12, 13, 119] systems
have mainly been used to characterize the kinetics of small molecules. Optical [15, 16, 17] and
electrochemical [18, 19, 20, 21] detection systems allow for measurements in pure or diluted
serum only for target molecules above the KDa range (mainly proteins and cancer biomarkers).
The R. E. Kunz group presented a bulk refractometric system based on an optical waveguide
[120] that is able to extract the calibration curves and kinetics of biotin (244 Da), even though
the system is rather complicated and difficult to scale down as a portable system.
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Other works based on sandwich-assay detection employ biomolecules conjugated to nanopar-
ticles. As already discussed in section 1.3, biomolecule labeling requires an additional oper-
ational step that, other than being costly and time-consuming, can alter the physiological
properties of the molecule itself. Hutter and Pileni used LSPR-based gold islands on glass
in combination with extra gold nanoparticles to form a sandwich assay and overcome the
difficulties in detecting small biomolecules [98]. However, the detection was performed by
immersion of the island-covered glass into buffer with thiolated DNA and measured with a
commercial spectrophotometer, without focusing on the implementation of a new detection
system.
The C. E. Furlong group [9] detected small molecules (cortisol in saliva) via competition
assay using a commercially available portable SPR system (SPREETA 2000) that still needed
temperature stabilization. Other works used more complex methods to amplify the SPR
response [121].
The S. Maerkl group published another relevant work reporting measurements in serum
[105]. They employed gold nanorods on glass and integrated plasmonics and microfluidics
monitoring in real time 32 sensing sites in parallel. They tested the system for the detection of
cancer biomarker (proteins), both in a direct and in a sandwich format, in a 50% serum matrix
down to 500 ng/mL concentration. Although the system is, in principle, scalable as a POC, it
employs a bright field transmission microscope that is far from a miniaturized POC system.
At present, label-free direct detection of small molecules in serum remains a challenge. The
manipulation of the small molecules with conjugated analytes or signal-enhancing particles
may alter the properties of the molecules themselves, while the multi-step detection via
sandwich or competitive assay requires extra preparation and prolongs the time of the assay
(1.3).
2.7 Biosensing with aptamers
Aptamers are an emerging topic of interest, as they can be created to recognize a specific
biomolecule (section 1.6). Works studying properties of aptamers and employing them in
biomolecular recognition assays without any chemical modification of the target have been
presented [46, 122, 123, 124, 125]. The direct characterization of small molecule-binding
aptamers is very challenging because high sensitivity is needed to detect low molecular weight
substances.
The K. Plaxco group presented a label-free system based on electrochemical interrogation of a
small molecule (cocaine) via structure-switching aptamers in a 50% blood serum matrix with
a limit of detection of 10 µM [11]. They took advantage of the conformational change of the
aptamers upon binding of the small molecule that make the sensor unaffected by non-specific
binding and easy to regenerate by immersion in buffer. However, the main focus remains on
the sensor and the biorecognition aptamer, rather than an innovative detection system.
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Another interesting system from the same group, based on colorimetric detection, employs
aptamers to detect a small molecule (cocaine) down to 1.25 pM [14]. In this case, the detection
is not label-free, as they used inhibition assay via a conjugated polyelectrolyte.
SPR-based systems have characterized kinetics and equilibrium-binding properties of ap-
tamers to small molecules [126]. A sandwich or a competitive assay is usually preferred for
small molecule detection with SPR-based systems. The Y. Du group [8] described the prepara-
tion of an array chip for high-throughput detection based on aptamers. They immobilized
plasmonic nanoparticles on a hydrophilic-hydrophobic patterned glass slide and enhanced
the LSPR signal thanks to gold NPs coupled to the aptamers. LSPR information was then
read with a laboratory microplate reader, so this system was not portable or suitable for
personalized medicine.
Jang et al. presented a nanocube-enhanced SPR system based on sandwich assays that used
aptamers for detecting cardiac biomarkers [127]. DNA aptamers were functionalized on a
gold surface and the antibody was conjugated with gold nanocubes. Although this approach
was very sensitive, as the aptamers are tested in undiluted human serum and concentrations
down to aM are measured, the complicated manipulation of both aptamer and antibody is
not convenient for a POC.
Each of the presented research efforts only implements one key aspect of the problem. For a
system to be suitable as a POC for personalized medicine in a real-life application, all of these
aspects must be combined. Therefore, it is highly desirable to have the advantages of label-free
direct detection into a portable, low-cost platform. The work presented here is an important
step for real-time detection of small molecules in undiluted serum by DNA aptamers via direct
assay with a portable, label-free, optical detection system into real-life applications.
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3 Principle of SPR based detection
The electromagnetic field of light incident on metal particles or thin metal films can excite
the free electrons inside the metal to collectively move, forming charge density waves, the
so called surface plasmon resonance (SPR). A SPR biosensor’s performance highly depends
on the underlying principle, its chemical interface and bio-functionalization, as well as the
optical, electrical and structural features of the reading instrumentation. This chapter gives
an overview on the concept of propagating SPR and on the Localized SPR, mainly focused on
the sensing features.
3.1 Propagating SPR
Surface plasmon polaritons (SPP) are travelling charge density waves associated with an
electric field propagating along the metal-dielectric interface and decaying exponentially
in the perpendicular direction to the interface. Most of the energy is confined to the metal
surface, making an SPR sensor highly sensitive to the changes that occur in the proximity of its
surface [52]. Binding of molecules to the surface causes changes in the local refractive index
(RI) and shifts the absorption spectrum peak towards longer wavelengths [128, 129, 130, 88].
Hence, this shift, measured as the change of the absorption curve’s peak wavelength, can give
quantitative information about the molecular layers on the surface (Figure 3.1) [131].
3.1.1 Excitation schemes
Direct excitation of SPPs by light beams is not possible unless special techniques to achieve
matching conditions between SPP and light are employed. This is usually achieved through
coupling devices, mainly by total internal reflection in a prism coupler, wave diffraction in
grating structures, or dielectric waveguides [52]. On planar metal-dielectric interfaces, the
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Figure 3.1: Plasmon peak location shift due to binding of biomolecules on the sensor surface
(left) and response curve of the biosensor over time (right).
wavevector of SPPs, k, is larger than the one associated with the incident light.
k = ω
c
p
²i (3.1)
is the wavevector of light propagating in a medium i of relative permittivity ²i , ω angular
frequency and c speed of light. In free space the wavevector becomes ωc or
2pi
λ0
, where λ0 is the
incident wavelength. However, the propagating SPR at the interface between a metal and a
dielectric has a wavevector of k = ωc
p
²m . Due to the fact that the dielectric constant of metals
²m is higher then the one of any dielectric material, special excitation schemes have to be
applied in order to reach the matching condition (Figure 3.2).
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Figure 3.2: Schematic of prism coupling for surface plasmon excitation (left) and illustration
of the corresponding phase matching condition (right).
A typical coupling device used to match the wavevector is a prism, in which the light is shined
above a critical angle such that total internal reflection at the interface of the two media is
obtained.
The amplitude of the wavevector k is expressed as: k2 = k2SPP +k2zi , with two components,
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one parallel to the plane of propagation, kSPP , and one in the direction perpendicular to the
interface, kz . In order to excite the SPP, the component of the light wavevector that is parallel
to the interface has to be enhanced by a factor of
p
²sinθ to match that of the surface plasmon
(² is the permittivity of the prism coupler and θ the angle of excitation).
Under these resonant conditions, a sharp minimum is observed in the reflected light. The
wavelength for which this minimum is measured, can excite the SPPs most efficiently and is
called resonance wavelength.
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Figure 3.3: Comparison of propagating (left) and localized (right) SPR-based biosensors.
3.1.2 Main characteristics of propagating plasmons
A SPR sensor based on propagating plasmons is characterized by three main parameters:
electric field enhancement, propagation length and penetration depth. The electromagnetic
(EM) field is confined at the metal-dielectric interface and decreases exponentially in both
media, depending on their permittivity.
If the excitation condition is fulfilled, the oscillating charges are in resonance with the external
driving field and cause a strong enhancement of the electric field at the metal-dielectric
interface. This resonance frequency depends on the thickness and optical properties of the
materials, and on the different complex permittivity between the metal (higher) and the
dielectric (lower).
The component parallel to the plane of propagation kSPP is expressed as:
kSPP = ω
c
√
²m²d
²m +²d
(3.2)
where ²m and ²d are the dielectric permittivity of the metal and of the dielectric, respectively.
The dielectric permittivity of a metal is a complex quantity
²m = ²′m + j²′′m , (3.3)
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as a result the SPP wavevector has a complex nature
kSPP = k ′SPP + j k ′′SPP , (3.4)
where the imaginary part describes the SPR wave attenuation due to metal absorption and
radiative losses. This means that the field intensity decays exponentially with a characteristic
decay distance of 12k ′′SPP
. The SPP propagation length δSPP is defined as
δSPP =λ0
(²′m)2
2pi²′′m
√(²′m +²d
²′m²d
)3
, (3.5)
where m refers to the metal and d refers to the dielectric [52]. For distances further than δSPP
the plasmon is strongly attenuated.
The plasmon propagation length affects the spatial resolution of the sensor and it is typically
in the range of 3-30 µm, depending on the characteristic of the system and exciting light [132].
In order to resolve two features on the same surface, they must be separated by a minimum
distance corresponding to at least ten times the propagation length.
The wavevector amplitude kzi is imaginary and thus expresses the exponential decay of the
EM field in the z direction. The penetration depth δi is defined as the distance at which the
intensity of the EM field inside the medium i (metal or dielectric) decreases to 1/e of its original
value at the interface.
δi = λ0
2pi
√∣∣∣²′m +²d
²2i
∣∣∣ , (3.6)
where ²i refers to ²′m or ²d depending on the direction considered for the decay of the EM
field. The plasmon penetration depth in the dielectric affects the sensitivity of the sensor and
it is typically in the range of 100-500 nm, depending on the characteristic of the system and
exciting light [85].
3.2 Localized SPR
Localized surface plasmons (LSPs) are excited in metallic nanostructures that have character-
istic dimensions smaller than the wavelength of the incident light. They are non-propagating
charge density waves occurring on suspended nano-sized metal particles and on metallic
nano-patterns [133, 134, 135, 136, 137, 138]. Excitation of LSP results in a peak in the extinction
spectrum that depends on the metal, on the geometry and on the properties of the surround-
ing dielectric [87, 139, 140, 141, 142, 143, 89, 144]. A regular, periodic pattern of nanoparticles
on a surface exhibits an extinction peak (caused by both absorption and scattering) in the visi-
ble and near-infrared range that can be narrowed by enhancing the regularity of the patterns
[145]. Changes in the local refractive index cause the plasmon peak to shift in wavelength.
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The penetration depth of LSPs is defined as the distance from the particle surface for which the
surface sensitivity is half the bulk sensitivity [52, 146, 147]. The LSPs evanescent field extents
into the dielectric medium typically in the range of 10-40 nm, depending on the nanoparticles’
size, pattern and materials.
The main advantages of Localized Surface Plasmon Resonance (LSPR) over SPR include
increased spatial resolution thanks to the non-connected pattern, simpler instrumentation
required for detection, and no need for temperature stabilization due to the lower bulk RI
sensitivity [86]. On the other hand, the fabrication of the nanostructures can be very costly
compared to thin film deposition.
3.2.1 Main characteristics of localized plasmons
The properties of LSPs can be modeled by assuming a spherical particle with dielectric permit-
tivity ²(λ) and with radius smaller than the wavelength of the exciting light. The incident field
E0 is considered to be homogeneous over the whole particle’s surface. A collective electron
motion is excited in the particle when light is incident.
dielectric environment εd
metal εm
incident light
k = 2pi/λ 2R
scattered light
E0
Figure 3.4: Scattering of light of a plasmonic nanoparticle.
The scattering efficiency of the particle exposed to homogenous electric field is expressed by
Q(λ)= 8
3
x4
∣∣∣∣ ²m(λ)−²d²m(λ)+2²d
∣∣∣∣2,x = 2piRλ (3.7)
where ²m and ²d are the dielectric permittivities of the metal and the dielectric, respectively,
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and the first coefficient 83x
4 is related to the particle size with respect to λ [148]. The resonance
condition depends on the permittivity of the background medium and it occurs when ²m(λ)=
−2²d .
Larger particles exhibit smaller and less sharp resonance, due to the fact that electrons have
to travel a longer distance. As the particle symmetry decreases, that is particles with more
complex shapes, the spectral features become more complex leading to multiple resonances.
3.3 Sensitivity and figure of merit
The sensitivity of a SPR based sensor is described as its ability to resolve small changes of RI in
the proximity of the surface. In order to be able to detect a binding event, the interaction must
occur within the extent of the plasmon. The sensitivity is then defined as:
S = ∆λpeak
∆n
(3.8)
where ∆λpeak is the shift in wavelength of the plasmonic resonance, while ∆n is the variation
in RI.
Sensitivity can be distinguished into bulk sensitivity, SB = ∆λpeak∆nmedium , that is changes in the RI
occurring homogeneously in the whole medium surrounding the nanoparticles, and surface
sensitivity, SS = ∆λpeak∆nl ayer , that is the changes occurring within a layer at the surface of the particle
[149].
The surface RI sensitivity is equal to the bulk sensitivity times a fill factor, η(0-1), that indicates
the fraction of LSP field volume filled by the layer (Figure 3.5). In other words, for a fixed layer
thickness, larger particles exhibit lower surface refractive index sensitivity [131, 150]. In the
case of biomolecular interaction that occupies the whole extent of the plasmon, the induced
RI variation produces a change in the real part of the propagation constant kSPP , Re{∆k},
which is directly proportional to the RI change ∆n:
Re{∆k}∼= k0∆n , (3.9)
where k0 denotes the free-space wavevector [131]. In order to compare different type of
sensors, the Figure of Merit (FOM) is defined as:
FOM= S
FWHM
(3.10)
where S is the sensitivity and FWHM is the full width at half maximum of the resonance
plasmon. The higher the FOM, the better the sensor. This means that high-performance
sensors should have high sensitivity and a sharp plasmon resonance (narrow FWHM).
The theoretical study presented in [85] compares the sensing performance of propagating
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Figure 3.5: Biomolecular interaction occurring within a short distance from the metal surface
and occupying a small portion of the plasmon (left). Biomolecular interaction occurring
within the whole extent of the surface plasmon (right).
SPR and localized SPR sensors. Continuous metal layers and gold nanorods are simulated
in order to extract and compare their FOM. The propagating SPR supported by the metal
layer exhibits decay lengths varying between 100 and 500 nm, while for single nanorods the
simulated distance is reduced to 50-80 nm from the nanoparticles surface, depending on the
particles’ geometry. This results in a one order of magnitude higher bulk RI sensitivity of the
propagating SPR with respect to the LSPR.
Analysis of the sensitivity shows for both propagating and localized SPR a linear increase with
increasing wavelengths. This is due to the larger penetration depth of the plasmons into the
dielectric for longer resonant wavelengths, thus providing a larger volume that is sensitive
toward RI changes.
The surface sensitivity has been simulated by modeling a 1 nm thick uniform coating over
the nanostructures. Both for propagating and localized SPR, the surface sensitivity decreases
for longer resonant wavelengths due to the larger penetration depth of the plasmon into the
dielectric (see Figure 3.5). Also experiments confirmed a 15 % higher surface sensitivity for
LSPR with respect to propagating SPR. Thus, for a nanoplasmonic sensor biosensing detection
should be carried out within 10-15 nm from the surface. Beyond that distance, the sensitivity
is strongly decreased.
Also Svedendahl et al. [86] did a comparison between the RI sensing capabilities of propagating
and localized SPR. They conducted measurements on 50 nm thick gold films and on gold
nanodisks featuring 120 nm diameter and 30 nm height. The same experimental conditions
and excitation wavelength of 700 nm were used in both cases. Water/glycol mixtures were
tested, obtaining bulk RI sensitivites of 3300 nm/RIU for the propagating SPR and 178 nm/RIU
for LSPR, that correspond to a FOM of 54 and 2, respectively. The higher bulk RI sensitivity
and FOM are due to the larger penetration depth of the plasmon into the dielectric, in fact
propagating SPR exhibits a 246 nm decay length, while the nanodisks exhibit a 30 nm decay
length because of their stronger electromagnetic field confinement around the nanoparticles.
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In this work, gold Nanoislands (NIs) evaporated on fluorine-doped tin oxide (FTO) on glass
have been employed (See Chapter 4). These nanostructures form a non-connected pattern
with irregular distribution on the surface due to the irregularity of the surface itself and the
random formation process. As a result, the plasmon resonance is broad (FWHM= 150 nm)
leading to a reduction of the FOM of the sensor. Nevertheless, they are extremely stable in
solvents. The details of the fabrication process and the sensing characteristics are described
in the next chapter.
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This chapter overviews the fabrication of the LSPR structures and some of their major lim-
itations in biosensing applications. Then, the fabrication process of the gold nanoislands
biosensor employed in this thesis is presented. Its application for the real-time sensing of
small molecules with the T-LSPR setup is presented in chapter 7.
4.1 Nanostructures for Localized SPR
In the last decades, the progress of nanofabrication made it possible to create nanostructures
with arbitrary geometries and nanometer precision [144, 151, 152]. Generally, nanofabrication
techniques can be divided into two main categories: top-down and bottom-up approaches.
Top-down approaches, which consist of gradually removing material from a base substrate
until the desired shape is reached, include commonly used techniques such as lithography,
electron-beam lithography and focused ion-beam milling [101], which offer freedom in design
and high precision.
Bottom-up techniques build on a base substrate the desired nanostructures by assembling
atoms, molecules or particles using diverse techniques, such as for example soft lithography,
nanosphere lithography (NSL) and direct evaporation. Such self-assembly approaches, in
contrast to for example e-beam fabrication, often do not rely on expensive machines or serial
processes and have thus been heavily used for biosensors development [146, 153, 154].
In NSL fabrication processes, self-assembled colloidal nanoparticles are utilized as either de-
position or etching masks to pattern periodic nanostructures [130, 87, 88]. The nanoparticles
have a regular size and are confined to a surface at a fixed interparticle spacing determined by
the size of the nanosphere mask.
The group of R. Van Duyne extensively used this technique, for example to fabricate triangular
silver nanoparticles (NPs) [130]. They tested the NPs’ sensitivity with alkanethiols of different
chain length and demonstrate that such NPs undergo structural changes when exposed to
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various solvents, which significantly affect the LSPR (see discussion in the next section 4.2).
S. Zhu et al. [142] use NSL to create rhombic and triangular NP arrays and compared their
sensitivity to bulk RI changes and surface modification with biotin-streptavidin. They reported
a higher spatial resolution and a higher sensitivity for the rhombic NPs, even though the
measurements were conducted in dry conditions.
The group of S. H. Oh investigated an inexpensive and high-throughput fabrication method
for nanoapertures used in EOT systems. They use a template-stripping procedure to pattern
periodic nanohole arrays [110, 117]. A silicon template is made via nanoimprint lithography
and reactive ion etching and features periodic arrays of deep circular trenches. Then a silver
film is deposited into the silicon template. The metal surface is then coated with a thin layer
of epoxy and covered with a glass slide. Then the metal layer is peeled off the template while
the mold remains reusable.
P. Chung and coworkers [101] presented a procedure for the fabrication of nanodimple arrays
by using a spin-coated double-layer colloidal crystal as structural template.
In the case of direct metal evaporation onto substrates [98, 95, 141], the morphology of the
islands film is determined by the evaporation conditions and the post deposition treatment
[129], and determines the shape, intensity and position of the plasmon resonance.
However, the major concern in the creation of nanostructures for biosensing is their stability
in wet environment, that is the mandatory condition to perform real-time measurements of
biomolecular binding events.
4.2 Stability of the LSPR nanostructures
In biosensing applications, nanostructures with stable and reproducible optical properties are
mandatory and define an efficient LSPR sensor.
Metal NPs fabricated on bare glass, mica or quartz substrates exhibit poor adhesion when
immersed in solvents [129, 97]. The structural instabilities of the particles in solvents cause
a change in their optical response. Often adhesion layers and coatings with organic or inor-
ganic layers are employed to protect the nanostructures and improve their stability in wet
environment [155].
Motivated by the poor stability of gold island films in water and other solvents, the group
of Rubinstein proposed a method to stabilize gold island films on glass while maintaining a
high sensitivity of the surface plasmon to analyte binding events [97]. Gold islands are coated
with a thin silica layer of about 1.5 nm deposited by a sol-gel procedure on an intermediate
mercaptosilane monolayer.
Another similar method is based on the coating of the gold nanostructures deposited on glass
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with an amorphous silicon-carbon alloy overcoating deposited in a controlled manner via
plasma-ehanced chemical vapor deposition [156].
The group of G. Borghs synthesized gold nanoparticles in solution and immobilized them on
quartz substrates by a silane layer as molecular glue [157]. The nanoparticles have been tested
with biotin/anti-biotin experiments, before which the NP-coated substrates were further
modified with a self assembled monolayer (SAM) of thiols (16- mercapto hexadecanoic acid).
Even if coating the nanostructures with a passivation layer is an effective method to protect
the nanostructures in wet environment, it is an additional step required in the biosensor
preparation and, depending on the passivation layer, it changes the surface chemistry than
can be applied. In addition, the SAM layer occupies a fraction of the sensitive detection region
determined by the plasmon extent in the dielectric medium, thus reducing its sensitivity
(Figure 3.5).
As an alternative, the group of Rubinstein proposed a non-connected gold pattern of 2.5
nm thickness evaporated on polystyrene slides (cut out of petri dishes) instead of glass and
obtained good adhesion in various solvents and tested on their islands with biotin-streptavidin
binding assay [96]. With the same objective, also S. Szunerits and co-workers [129] replaced
the glass substrate with indium tin oxide (ITO).
In the present work, gold nanoislands (NIs) are formed on fluorine-doped tin oxide (FTO)
coated glass slides, as explained in the next paragraph.
4.3 Sensor based on gold nanoislands
The gold NIs employed in this work were realized by direct thermal evaporation and by
subsequent mild thermal annealing (200°C overnight). No seed-mediated growth or additional
adhesion layers were employed [158], thus involving a reduced-complexity process. NIs were
formed on FTO coated glass slides. The usage of FTO coated glass instead of plain glass
significantly improves the stability of gold NIs. In fact, gold penetrates in the porous SiO2 layer
during thermal annealing [159]. FTO coated slides are characterized by excellent adhesion
properties while showing high optical transmittance and conductivity. The latter is desirable
to perform comparative characterization techniques such as electrochemical and Scanning
Electron Microscopy.
As a substrate, 5.3 cm × 1.2 cm FTO-coated glass slides were prepared by 20 minutes sonication
in a 1:1 solution of 2-propanol and acetone, followed by abundant rinsing with ultra pure
water and drying with pure nitrogen.
A layer of 5 nm of gold was evaporated on one surface at RT at 3×10−6 mbar at a rate of 0.0016
nm/sec. The layer thickness was monitored by a built-in quartz balance. Vacuum evaporation
was followed by a thermal annealing overnight at 200°C.
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Figure 4.1 shows the evaporated gold layer before (A) and after (B) the annealing process.
After mild heating, gold reorganizes in small clusters giving rise to a well-defined plasmonic
peak (Figure 4.2B). Conversely, the extinction spectrum of the FTO-coated slide right after
evaporation does not feature a well-defined peak (Figure 4.1) corresponding to a connected
pattern.
Figure 4.1: (A) SEM image of a thin gold layer evaporated on a FTO glass substrate. (B) SEM
image of gold NIs formation after thermal annealing [1].
Figure 4.2: (A) Extinction spectrum of a sample after gold evaporation. (B) Extinction spectrum
of a sample after evaporation and subsequent annealing [1].
4.4 Surface modification of the nanoislands
The gold NIs FTO-coated slides were functionalized using the following protocol.
DNA probes immobilization on gold was achieved by sulfur-gold bond. The NIs FTO-glass
slides were incubated at room temperature for 16 hours in a PBS buffer solution containing
the 5’-thiolated-CAG TGA GGC GTG GCC AGG G-3’-oligonucleotide (ssDNA).
After the incubation, the samples were rinsed with PBS buffer and ultra pure water and then
gently dried with pure nitrogen. The light extinction of the samples was measured prior and
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after surface ssDNA immobilization.
A reference slide was prepared to estimate the peak shift due to NIs aging and modification in
liquid environment. We immersed NIs FTO-coated glass slides for 24 hours in PBS buffer, the
same buffer used for the ssDNA immobilization process.
The sample was rinsed with ultra pure water and dried with pure nitrogen.
The formation of the ssDNA layer on surface is verified by means of a commercial spectropho-
tometer (Ocean Optics 2000+) by recording the NIs FTO-coated glass slides transmission
spectra prior and after surface modification. A complete characterization of the formation of
the ssDNA layer on surface is described in the next chapter.
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5 Peak shift determination with T-LSPR
setup
We aim at the observation of the plasmon peak location due to biomolecular binding events
on a sensor surface. In this chapter the first prototype of a portable T-LSPR setup and the
algorithm used for the extraction of the plasmon peak location are presented.
The setup is an electronic-based implementation of T-LSPR that avoids bulky equipment such
as spectrophotometers and monochromators, while exhibiting excellent repeatability in the
peak wavelength determination. It is based on light emitting diodes (LEDs) as a light source, a
photodiode as a detector and on on-board signal amplification.
The peak location is extracted by a fast iterative curve-fitting algorithm, which is suitable for
implementation on a limited-power computing platform (e.g. a 32bit microcontroller).
The system was tested in dry conditions on DNA-modified gold NIs evaporated on FTO-coated
glass slides but in principle it is suitable for any transparent surface exhibiting a LSPR effect.
5.1 T-LSPR based setup
Our low-cost measurement approach is based on the observation that the information content
of the complete transmittance curve is limited and that the key parameter of interest in T-
LSPR measurement is the peak shift of the surface plasmon. Thus, we developed an ad-hoc
technique for measuring the surface plasmon peak shift observed in transmittance using
low-cost components and a highly streamlined optical setup.
We measure the peak shift by illuminating the sample with a limited number of different
color LEDs. Since the intensity of the peak changes as well as the location, at least three LEDs
whose spectra cover the peak region are needed to identify the peak shift. The peak location
is estimated from the three measured intensities by means of an innovative interpolation
technique that will be discussed in section 5.2.
A typical surface plasmon transmission spectrum of gold NIs evaporated on a transparent
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slide is plotted in Figure 5.1 (dashed curve, left axis); it has been measured with a UV-Vis-NIR
spectrophotometer Jasco V-570 in transmittance mode with a scan speed of 200 nm/min and
a bandwidth of 1 nm. Transmittance is normalized with respect to bare FTO slides. The peak
is located between 550 nm and 595 nm and red-shifts upon modification of the NIs with layers
of organic molecules (solid line).
The peak wavelengths of the LEDs spectral distributions are chosen to be across the SP peak
and are respectively of 525 nm, 590 nm and 650 nm. Moreover, the NIs layer modifies the LEDs
spectra when the light passes through it, resulting in an altered (filtered) spectral distribution
(Figure 5.1, dotted lines, right axis). The three crosses indicate the transmittance values
measured with the three LEDs light sources.
Figure 5.1: Example of a typical gold NIs spectrum (dashed line) measured with a UV-Vis-NIR
spectrophotometer Jasco V-570 in transmittance mode with a scan speed of 200 nm/min,
bandwidth 1 nm. The solid line represents the curve shift after NIs surface modification with
organic molecules. The three crosses indicate the transmittance values measured with the
LEDs system plotted at the LEDs effective wavelength. The dotted lines represent the LEDs
spectral emissions normalized at their respective maximum emission values and filtered by
the photodiode characteristic after passing through the layer of gold NIs.
5.1.1 Setup description
We selected Kingbright 1.0 mm × 0.5 mm SMD LEDs with a 120° viewing angle characterized by
a Full Width at Half Maximum (FWHM) of 30 nm, 20 nm and 28 nm, respectively. At a forward
current of 20 mA the LEDs have a luminous intensity of 110 mcd to 300 mcd for pure green,
50 mcd to 150 mcd for yellow, and 70 mcd to 220 mcd for red. LEDs light intensity emission
has been monitored over 60 minutes. Despite an initial transient of about 10 seconds, the
emitted light showed for all the LEDs constant drifts of −10−7 V/s, −3×10−7 V/s, −2×10−7
V/s for green, yellow and red, respectively. Figure 5.2 shows the portable T-LSPR setup. The
NIs layers evaporated on slides are placed between the array of LEDs and a photodetector that
detects the light intensity transmitted through the sample. The LEDs and the photodiode are
mounted on a system of two printed circuit boards (PCBs), whose power supply is provided by
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Figure 5.2: (A) Digital rendering of our transmission setup. (B) Frontal view showing the
location of the light sources, sample and photodetector. (C) Schematic view of the setup.
an Agilent E3631A. The two PCBs are placed inside an aluminum box that has been treated
with an anodization process to make it matte black, such that the light emitted by the LEDs is
not reflected by the internal walls and that the external light is screened at the same time. The
box presents sets of parallel lateral grooves in the internal walls for PCB holding.
In between, there is a tray equipped with a sample holder adaptable to different sample dimen-
sion by means of moving elements and screws. The setup is equipped with a low noise and low
vibration fan (Multicomp GM0500PEV Series) to maintain the LEDs at a constant temperature.
In fact, measurements conducted with a thermocouple placed inside the instrument showed
that the LEDs luminous intensity decreases by about 0.4% for the green LED and 0.8% for the
yellow and red LEDs per degree of temperature with respect to the LEDs emission at 25°C.
We measured a shift of 1 nm for a variation of 0.43%, 0.63% and 0.39% of the light intensity
emission for the green, yellow and red LEDs respectively. Overall, 1°C of temperature increase
leads to a 0.6 nm shift, therefore, if not controlled, a temperature variation could lead to a false
peak estimation.
The LEDs are current-supplied by a high-speed JFET-input operational amplifier (TL081)
and controlled independently by means of 2N7000 N-Channel FETs, so as to illuminate
alternatively the sample with spectral distributions centred on the three different wavelengths.
The LEDs are spaced by 2.2 mm. The voltage at the non-inverting input of the amplifier is
obtained through a voltage divider, dimensioned taking into account the maximum forward
currents of the LEDs.
The light intensity can be tuned in real-time by a Data Acquisition Board (NI USB 6281 M
Series) that controls the voltage divider and the activation of the LEDs. The LEDs are switched
on with a cycle time of 45 seconds and a duty cycle of 33%. The light transmitted through the
NIs-coated slides is detected by a photodiode (HAMAMATSU S1337-33BR) operating in the
photovoltaic mode mounted on the second PCB. The photodiode has a quantum efficiency
ranging from 0.25 to 0.45 in the plasmon peak region.
The photovoltaic configuration is particularly suitable for our low-frequency setup, leading
to low noise output and reduced dark current. The current generated by the photodiode in
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response to the transmitted light is then converted to voltage by a transimpedance amplifier,
whose gain can be adjusted by selecting the proper resistance out of four possible values
(10kOhm ÷ 80 kOhm) available in the feedback loop. The OPAMP CA3140EZ is a BiMOS
operational amplifier featuring input gate-protected MOSFETs, which allows the measurement
of very low input currents (stray input current 10 pA).
A capacitor connected in parallel to the resistances is added to filter out high frequency noise.
The output voltage of the amplifier is measured by the DAQ board setup and presents a noise
level of about 15 µV (see Section 5.3).
5.2 The algorithm for peak extraction
Our system aims at characterizing the surface plasmon peak shift observed in the extinction
spectrum in response to a biochemical event, by illuminating the sample with a limited
number of LEDs.
This shift is estimated by identifying the peak location before and after the NIs surface modi-
fication with organic molecules. We developed an algorithm that extracts the peak location
employing the LEDs transmittance measurements. The presence of molecular layers on the
surface of gold NIs determines a red shift on the SPR spectrum but does not affect its shape
significantly.
In order to fit the experimental data, the algorithm employs a curve representing qualitatively
the typical plasmon peak shape (TNI (λ) ). Such a curve can be obtained by the extinction
spectrum of any sample of the batch, since the shape is not significantly sample-dependent.
However, in this work we obtain the peak-shape representative curve by averaging extinction
spectra obtained on several samples, to smooth sample variability effects.
The algorithm takes into account the non-ideal spectral characteristics of the light sources
and of the photodetector, as they contribute to the transfer function of our system. In fact,
the LEDs have bell-shaped spectra fLED (λ) normalized to their maximum emission value
with a specific FWHM. Besides, the photodetector has a quantum efficiency spectrum fPH (λ)
variable in the SP peak range.
Therefore, for a given LED ‘i’, the following expression corresponds to the TNI (λ) read by the
system of that LED and photodetector:
λ2∑
j=λ1
TNI (λ) · fLED,i (λ) · fPH (λ) ·∆(λ j ) (5.1)
Here we approximate the integral over λ with a summation as the discretization error is
negligible if we take fine-grained samples (in this case we took 4’000 samples in a 400 nm
range), while computational speed significantly improves. The mathematical expression of
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the transmittance of the reference sample is:
TLED,i =
∑λ2
j=λ1 TNI (λ) · fLED,i (λ) · fPH (λ) ·∆(λ j )∑λ2
j=λ1 fLED,i (λ) · fPH (λ) ·∆(λ j )
(5.2)
where λ1 and λ2 are the extremes of the considered wavelength range, and ∆λ is the wave-
length increment. TLED,i represents the theoretical transmittance value calculated for the LED
‘i’. The algorithm iteratively translates TNI (λ) in the x and y directions, i.e. wavelengths and
transmittance values, respectively, with small increments δx and δy :
TNI (λ,δx ,δy )= δy +TNI (λ+δx) (5.3)
This iterative translation is carried out in the 350 nm - 750 nm range where the SPR occurs. At
each translation step, TLED,i is calculated and compared to the experimental measurements.
The algorithm determines the translation parameters that minimize the root mean square
error between the set of theoretical values and the experimental ones. The curve obtained
by the corresponding translation provides the best estimation of the peak location of the
transmittance spectrum.
At every translation step along the x axis, the TLED,i points are calculated for all the LEDs for
every possible translation in the y axis; the algorithm computes the root mean square error
between those points and the experimental values yLED,i .
In other words, the optimization routine tries to identify the parameters δx and δy that
minimize the Euclidean distance between the vector (yLED,1, . . . , yLED,i , . . . , yLED,N ) and the
vector (TLED,1, . . . ,TLED,i , . . . ,TLED,N ).
This procedure can be mathematically expressed by the following formula:
argminδx ,δy

√√√√ N∑
i=1
[yLED,i −TLED,i ]2
 (5.4)
At the end of the elaboration, the optimal δ∗x and δ∗y parameters are found and the wavelength
corresponding to the peak of the curve is extracted (Figure 5.3).
5.3 Repeatability of the peak wavelength determination
The portable system for T-LSPR has been characterized in terms of measurement error on a
NIs FTO-coated glass slide.
The output of the system is a voltage ranging from few volts to tens of volts depending on the
active LED. The average output voltage over 6 subsequent measurements is 12.17 mV± 14.64
µV for the green LED, 3.28 mV± 19.12 µV for the yellow LED, and 8.18 mV± 15.26 µV for the
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Figure 5.3: Fitting of the LEDs experimental data. The three stars represent the intensity
measured by enlightening the sample with the LEDs and they are plotted at the LEDs effective
wavelengths. The dashed curve represents the typical plasmon peak shape (TNI (λ)) and the
two double arrows, δx and δy , indicate the direction in which the curve is shifted in order to
fit the experimental data. δ∗x and δ∗y are the optimal values extracted by the algorithm that
correspond to the best data fitting.
red LED. Each measurement is an average of 40 kSamples taken at a rate of 100 kSamples/s.
The peak wavelengths extracted by means of the algorithm (see Section 5.2) from these 6
measurements have a maximum deviation of 1.1 nm as shown in Figure 5.4 A.
Figure 5.4: (A) The measurement and extraction of the peak location of a NIs coated slide has
been repeated 6 subsequent times. The maximum deviation among the 6 measurements is 1.1
nm. Each measurement has an error bar between 1.2 nm and 1.3 nm given by the standard
deviation over the 40000 samples. (B) The NIs-coated slide has been removed from the sample
holder and place it back in between each of the 6 measurements [1].
To evaluate the error due to a different positioning of the NIs-coated slide on the sample holder,
we removed the slide from the holder and placed it back in between each measurement for 6
times. The peak wavelengths extracted by the algorithm have a maximum deviation of 0.9 nm,
while the error bars range from 1.5 nm to 2.8 nm. The results are shown in Figure 5.4B.
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In order to test the impact of the choice of the fitting curve representing the typical peak shape
(Section 5.2), we compared the results obtained using the same identical spectrum for any
sample with respect to the employment of the spectrum corresponding to a specific sample.
The two procedures do not lead to significant difference in the value of the extracted peak. In
this work, we used a spectrum obtained from averaging all the samples of the batch.
5.4 Measurement of the peak shift due to a ssDNA layer formation
A batch of 11 NIs-coated slides has been prepared with the self-assembly process in order to
obtain a layer of ssDNA on the gold surface. The peak locations have been determined for
every sample before and after surface modification by means of the LEDs-based measurement
setup and by the extraction algorithm described in Section 5.1 and 5.2, respectively. The
average peak shift obtained upon DNA immobilization on the 11 samples corresponds to 7.24
nm with a standard deviation of 1.65 nm. A typical peak shift is shown in Figure 5.5.
Figure 5.5: Peak shift of a NIs sample before (solid line) and after surface modification with
ssDNA (dotted line) as extracted by means of our LEDs-based setup and extraction algorithm.
Transmission is calculated with respect to a FTO-coated slide.
The same samples have been also characterized by means of a Jasco V-570 Spectrophotometer
(Perkin Elmer). The obtained average peak shift after the molecular layer formation corre-
sponds to 5.18 nm with a standard deviation of 1.94 nm (instrument bandwidth 1 nm). We
consider the difference in the average peak shift estimated by our LEDs-based setup and by
the spectrophotometer to be due to a different contribution of the scattering effects in the two
sample cells.
In order to evaluate the stability of the NIs peak in liquid environment we measured a reference
sample prior and after incubation in Phosphate Buffered Saline solution 1X. The incubation
did not lead to an appreciable peak shift. This measurement demonstrates that the peak shift
observed after ssDNA immobilization is actually due to the presence of the molecular layer
and not to conformational changes of the NIs in a buffer solution.
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Other works based on T-LSPR that employs single wavelength measurements [39] have been
published. The advantage of our instrument compared to single-wavelength measurements is
that we have three discrete light sources that enable the identification of the peak position in
wavelength. We are interested in this feature for two reasons: 1) we want to compare our setup
with a standard UV-Vis spectrophotometer in its ability to describe the full spectrum of the
plasmon. 2) Many publications in the surface plasmon field report that the molecular changes
at the interface affect directly the plasmon peak position [145]. Moreover, our approach has
the advantage to measure and monitor the possible broadening of the plasmon in case the
plasmonic structures are unstable.
5.5 Summary
We designed and implemented a portable setup for T-LSPR measurements with 1 nm preci-
sion on the plasmonic peak extraction. The sensor is fully-portable, low cost and suitable for
real-time detection. It is based on electronically-driven power LEDs and integrated instrumen-
tation amplifiers. We developed a novel data analysis approach that extracts the key signature
of the LSPR spectrum from the measurements with a set of three LEDs, emitting in the visible
region.
In this work, we tested our LEDs-based setup on NIs FTO-coated slides. The accuracy in the
peak location determination has been characterized. The uncertainty due to the measurement
error and the software extraction procedure leads to a 1.1 nm maximum deviation over 6
repeated measurements. NIs have been modified with ssDNA and the resultant LSPR peak
redshift has been characterized over 11 samples. We found that the response of our LEDs-
based device combined with the fast algorithm tracks very well the plasmonic shift extracted
by standard UV-Vis spectrophotometer.
The results presented demonstrated the remarkable performance of our simple, low-cost setup
and peak extraction algorithm with respect to a high-end spectrophotometer. The system
was tested on evaporated gold NIs on FTO-coated glass slides, nevertheless it is compatible
with any surface exhibiting a localized SPR effect. Furthermore, the T-LSPR configuration is
suitable to be scaled down to sub-micrometer detection areas and parallelized as a detector
array. The choice of using low power-consumption components makes the device suitable for
low-cost and portable bioanalytics applications, as in the case of POCs.
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format with CMOS image sensor
An improved version of the T-LSPR setup presented in the previous chapter has been designed
and developed in order to perform parallel array measurements. The goal is to characterize in
real-time multiple binding events occurring on the same biosensor surface. The improved
system features a broad spectrum LED and a CMOS image sensor, it is scaled down to a palm
size and it is powered by computer via USB connection.
In this chapter, a complete description of the system is presented. The peak extraction
algorithm has been adapted to the new features of the T-LSPR system and a new parameter
for the wavelength evaluation, the hue, is introduced. At last, the characterization of the NIs
biosensor response to bulk refractive index changes is presented and the calibration curves
and figure of merit are calculated.
6.1 Optical setup for real-time detection
The T-LSPR setup is a self-contained system that employs a non-polarized white light LED
(Cree Lamp XP-E supplied by 2.49V) as excitation source and a CMOS image sensor (ST
Microelectronics VW6558) as a light detector. The transmitted light through the NIs coated
slides is affected by the plasmonic resonance phenomenon occurring at the NIs-solution
interface.
The light is collected by the CMOS detector through a plano-convex lens (Thorlabs LA1270-A)
that reduces the focal distance between the NIs coated slide and the CMOS sensor. Relative
distances among the elements of the optical setup are represented in scale in Figure 6.1 A) and
6.1 B).
The use of an image sensor allows for arrays spotting enabling to monitor multiple surface
reactions at the same time. The dimensions of the CMOS sensor are 3.5 x 3.03 x 2.5 mm3. It
has an integrated lens with focal length of 1.25 mm and horizontal field of view (HFOV) of 60◦.
The resolution is 648x488 pixels with red (R), green (G) and blue (B) filters in a Bayer pattern
configuration. The size of each pixel is 2.2 µm x 2.2 µm.
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A) B) C)
Figure 6.1: A) Digital rendering of the components of the optical setup. B) Side view with
relative distances in scale among the components. C) Picture of the T-LSPR setup.
A diffusor is placed at 10 mm distance from the LED to improve the light uniformity and to
prevent hot spots on the image. All the setup components are placed inside a 3D printed case
of size 5.5 cm x 6 cm x 8.5 cm (Figure 6.1 C)). The black material is chosen in order to have
very low internal reflections.
6.2 Microfluidic plasmonic chip for molecular analytics
The microfluidic chip is composed of a glass slide coated with gold NIs (described in Section
4.3) and a microfluidic module.
Microfluidic channels for the delivery of Tobramycin solutions to the DNA aptamer on the
surface are built by mounting a cover plate on top of the NIs FTO-glass slide. The cover plate
is made out of Polymethyl Methacrylate (PMMA) and it is held on the NIs FTO-glass slide by
a double coated tape (3M High Performance Double Coated Tape 9086). The channels’ size
(2 mm x 14 mm x 150 µm) corresponds to the pattern on the tape by laser micromachining
(Figure 6.2).
Figure 6.2: Picture of the microfluidic plasmonic chip.
Inlets and outlets are 0.8 mm in diameter such that microfluidics connections are possible
from standard syringe needles (Terumo) connected to the syringe pump (Harvard Apparatus
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11 Elite Nanomite Programmable Syringe Pump) via flexible silicon tubes (Sani-Tech STHT-C).
6.3 Data analysis
Images of 200x300 pixels were recorded at 8 frames per second with an analog gain set to 1,
they were saved in a sequential order in bitmap format and were displayed in real-time on the
screen. Regions of interest (ROIs) of about 800 pixels were manually selected on the images in
order to include the functionalized areas (Figure 6.3). RGB intensities were then averaged for
each ROI yielding to the corresponding output signal used for further data analysis.
Image analysis was then performed by either determining the plasmonic peak location (wave-
length) using an algorithm we developed (5.2), or by calculating the hue change.
Figure 6.3: Schematic representation of a NIs FTO glass slide indicating the spots on surface
and the areas exposed to the microfluidic channels (right). Example of image acquired by
the CMOS camera (left). The ROIs are selected during the data processing. 1) Reference FTO
surface. 2) Aptamer spots. 3) MCH control spots.
6.4 Adaptation of the algorithm to the new setup
For each ROI of each image, the R, G and B values for light transmittance are mediated over
the ROI. This set of three discrete points is used by the algorithm to extract the plasmon peak
location in wavelength.
The biomolecular binding event on the surface induces a redshift of the plasmon peak without
altering its shape, the latter being an intrinsic characteristic of the gold NIs. The characteristic
plasmon resonance of the gold NIs FTO-coated glass slide is used as a reference curve in the
algorithm. The algorithm takes into account the spectral characteristics of the white LED and
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Figure 6.4: Example of a typical gold NIs spectrum (blue dashed line) measured with a UV-Vis-
NIR spectrophotometer Jasco V-570 in transmittance mode with a scan speed of 200 nm/min,
bandwidth 1 nm. The solid line black line represents the white LED emission. The dashed
blue, green and red lines represent the RGB filters of the CMOS image sensor normalized at
their respective maximum values and the continuous blue, green and red lines are the same
curves convoluted with the LED spectrum.
the RGB filters used in the optical setup.
At each iteration, the reference curve is shifted in wavelength and transmittance until the best
fit with the set of three measured points is reached and the peak location is estimated. The
detailed description of the algorithm can be found in 5.2.
6.5 Hue calculation
Raw data were first converted from Bayer pattern to RGB values and then converted into the
HSV (Hue, Saturation, Value) color-space. In the HSV colorspace the hue (H) value corresponds
to the perceived color tone and thus indirectly to the physical wavelength, therefore it is a
candidate parameter to evaluate the spectral variations of the plasmon resonance peak in the
spectrum. It uniquely depends on the measured combination of red, green and blue pixel
values and it is independent of the overall luminous intensity, as proven experimentally and
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Figure 6.5: Hue calculation for different light intensities. The pink and cyan lines represent the
light intensity for a NIs and a bare FTO spot on surface, respectively, modified by changing the
LED feeding current. The corresponding hue is represented by the red and blue lines and it is
independent on the luminous intensity of the light.
shown in Figure 6.5.
A 2 hours experiment conducted by varying the feeding current of the LED, such to increase
and decrease the luminous intensity reaching the CMOS pixels, proved that the hue remains
constant independently from any light intensity variation.
For each image and for each selected ROI, the hue of the average of the selected pixels is
calculated (as in Equation 6.3) and low-pass filtered (filter order of 126, cutoff frequency of
0.00438 Hz). The variation of the hue was then used to display the plasmonic changes over
time.
MAX=MAX(R,G,B) (6.1)
min=min(R,G,B) (6.2)
H ′ =

G−B
MAX−min if MAX=R
B−R
MAX−min +2 if MAX=G
R−G
MAX−min +4 if MAX=B
 (6.3)
H= H
′
6
(6.4)
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H=H+1 if H<0 (6.5)
6.6 Stability of the NIs layer in aqueous solution
The stability of the gold NIs was tested by measuring the NIs FTO-glass prior and after 24
hours immersion in TE 1X buffer. Extinction spectra measured with a commercial spectropho-
tometer (Ocean Optics 2000+) show no appreciable shift.
In order to test the NIs adhesion in presence of a flow of solution, the microfluidic module
was mounted on the NIs FTO-glass slide, as described in 6.2, and TE buffer is flushed for 10
minutes at 5 µl/min. The absence of change in the signal proves the stability of the gold NIs
under flow.
6.7 Refractive index sensing in bulk
In order to determine the sensitivity of the NIs FTO-coated slides to bulk refractive index
changes, the microfluidic module is mounted on the slides, as described in paragraph 6.2, and
solutions with diverse RI values, prepared as reported in [160], are delivered to their surface.
Figure 6.6: Bulk Refractive Index response of the NIs FTO-coated glass slide to glucose/sucrose
solutions injections with increasing RI values expressed in hue variation. The blue and red
vertical lines indicate when the glucose/sucrose solution and the ultra pure water reach the
sensor’s surface, respectively.
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Figure 6.7: Bulk Refractive Index response of the NIs FTO-coated glass slide to glucose/sucrose
solutions injections with decreasing RI values. The blue and red vertical lines indicate when
the glucose/sucrose solution and the ultra pure water reach the sensor’s surface, respectively.
Ultra pure water, that has RI of 1.33, is used as reference solution. For RI between 1.34 and
1.37, the solutions are prepared by glucose dilutions in ultra pure water. From 1.385 to 1.445
the solutions are prepared by sucrose dilutions in ultra pure water.
Every glucose/sucrose injection is alternated with an injection of ultra pure water, that is
referred to as the baseline of the experiment. The presence of solutions with higher RI with
respect to water in contact with the NIs surface makes the plasmon peak location to redshift.
Figures 6.6 and 6.7 show the glucose/sucrose injections delivered to the surface in increasing
and decreasing concentrations, respectively. During the experiments, the solutions with RI
1.37 and 1.445 have been repeated twice consecutively in order to verify that the plasmon peak
shift measured was not due to a drift or instability of the nanostructures.
Solutions with high RI values present increased viscosity, as it is visible in Figure 6.6 starting
from RI 1.385, where the transition from the glucose solution to the water baseline is slower. In
Figure 6.7 the water injections in between two consecutive glucose/sucrose high RI solutions
have been prolongated in order to reach a stable baseline before the next glucose/sucrose
injection. Also in this case, the high viscosity is evident as a smoother transition from the
glucose/sucrose solution to water.
The plasmon shift has been evaluated in term of plasmon peak location, as extracted with the
algorithm (6.4), and as related to the hue (6.5). A direct comparison between peak location
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Figure 6.8: Bulk Refractive Index response of the NIs FTO-coated glass slide to glucose/sucrose
solutions injections with increasing RI values expressed in peak location shift (nm). The blue
and red vertical lines indicate when the glucose/sucrose solution and the ultra pure water
reach the sensor’s surface, respectively.
extraction and hue calculation is discussed in the next chapter (7.3).
6.7.1 Calibration curve and figure of merit
The bulk RI plasmon peak shifts plotted against RI value show a linear trend with a sensitivity
of 36.7 nm/RI (Figure 6.9).
The characteristic plasmon shape of the gold NIs FTO-coated glass sensor has a FWHM of
150 nm (Figure 4.2). In order to be able to compare the performance of our sensor with other
different structures, the FOM (see section 3.3) of the NIs FTO-coated glass slide sensor to bulk
RI sensing, calculated as in Equation 3.10, is 0.24.
The sensitivity of LSPR sensors to changes in RI is highly dependent on the plasmon charac-
teristics such as the penetration depth, spectral linewidth and electromagnetic field strength
(see section 3.2). In order to increase the FOM of a LSPR sensor, the sensitivity should be
increased or the FWHM should be reduced, that can be achieved by improving the regularity
of the nanostructures in shape and pattern.
Many groups investigated various nanostructures with different tecnhiques in order to increase
the sensor performance, as it is the case of C. Huang [161] that fabricated gold nanorings on
quartz using NSL featuring RI sensitivity of 350 nm/RIU (Refractive Index Unit) with a FOM
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Figure 6.9: Bulk Refractive Index sensitivity expressed in peak location wavelength (left) and in
hue variation (right).
of 3.1. The group of R. Van Duyne [162] developed LSPR sensor based on nanowell surfaces
covered by a silver film exhibiting a sensitivity of 538 nm/RIU and a FOM of 14.5. The same
group developed silver triangular nanoprisms [88] featuring a sensitivity of 205 nm/RIU and a
FOM of 3.3.
More complex structures, as the case of plasmonic mushrooms composed of a gold cap on a
photoresist pillar located on a gold film [102] and featuring a FOM of 108 (FWHM 10 nm and
1010 nm/RIU) tested in dry conditions, and other systems with very narrow FWHM and high
FOM, as in the case of EOT systems [109, 110, 112] have been presented.
The evaluation of sensitivity in dry conditions is only partially relevant in biosensing. First of
all, the stability of the biosensor to solvents should be verified as the nanostructures must not
undergo conformational changes, afterwards, measurements conducted in wet environment
can change the overall conditions of the measurement system (as for example light scattered,
light transmitted, ...).
With respect to the above mentioned sensors, our NIs FTO-coated slides have a much higher
FWHM and lower bulk RI sensitivity, leading to an overall low FOM. This is mainly attributed
to the limited-controlled in size NIs fabrication process and to the irregular FTO surface on
top of which the gold is evaporated (Figure 4.1).
Nevertheless, the presence of the irregular structure of the FTO layer is fundamental for the
stability of the NIs in wet environment. The stability of the nanostructures and their resistance
in solvents and in high ionic strength solutions is the most critical feature [161, 88, 156, 96, 130].
The gold NIs employed in this work can withstand high ionic strength solutions for long time
and under continuous flow without any passivation or other surface modification needed (see
Section 4.2), while keeping unaltered the nanostructures and their sensing properties.
53

7 Real-time direct detection of small
molecule binding in saline buffer and
in serum
In this chapter the real-time experiments of biomolecular binding conducted with the T-LSPR
setup are presented. In particular, a selected DNA aptamer developed in our laboratory is
tested on the NIs FTO-coated to recognize tobramycin, a small molecule drug (467 Da) via a
label-free direct assay. The experiments have been conducted, at first, in saline buffer and,
then, in undiluted serum.
7.1 NIs surface functionalization and samples preparation
The DNA aptamer specific for tobramycin was previously developed in our lab [47] (5’-
TCCGTGTATAGGTCGGGTCTCTTGCCAACTGATTCGTTGAAAAGTATAGCCCCGCAGGG-3’) and
it was purchased from Sigma (Switzerland) with a 5’-thiolated end.
DNA aptamers were immobilized on gold via sulfur-gold bonds. The NIs FTO glass slides
were incubated at room temperature for 16 hours in a PBS buffer solution of DNA aptamer
3µM. After the incubation, the slides were rinsed with ultra-pure water and gently dried with
nitrogen.
The surface was then passivated with mercapto-6-hexanol (MCH, Sigma) 1mM in TE 1X for 30
minutes. The prepared slides were than thoroughly rinsed with ultra-pure water and dried by
nitrogen stream.
NaCl, PBS, and Fetal Bovine Serum (FBS) were purchased from Sigma (Switzerland), while TE
buffer was purchased from Applichem.
Tobramycin samples were prepared in either TE1X buffer or in FBS, in which case they were
subsequently filtered with Amicon Ultra Filter (Milli-pore, Switzerland) with 3 kDa cut-off in
order to remove most of the protein content.
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7.2 Handling of solutions by microfluidics
Microfluidics was built on top of the NIs FTO-glass slide such that two independent channels
are covering the areas spotted with the DNA aptamer, the MCH reference spots, a bare gold
NIs area and a blank FTO area (Figure 6.3).
For all the experiments, surface conditioning was performed by injecting 1M NaCl regeneration
solution followed by running buffer. Solutions with different concentrations of tobramycin
were tested. After every injection of tobramycin, TE 1X buffer was injected in order to observe
tobramycin dissociation from the surface. Eventually, NaCl was used to remove the remaining
tobramycin molecules on the surface, thereby regenerating the surface.
7.3 Small molecule analysis with a custom made T-LSPR system and
DNA aptamers
The selected DNA aptamer was tested on a planar gold surface with a standard propagating
SPR based system [47], however it was never tried on non-connected patterns and detected by
a custom made T-LSPR system. Our T-LSPR setup consists of FTO glass slides covered with
non-connected gold NIs.
In order to assess the T-LSPR setup capability to detect surface binding of small drugs, the
gold NIs were functionalized with the DNA aptamers for tobramycin. The surface binding
of tobramycin is detected by monitoring the refractive index (RI) change in the proximity of
the NIs by looking at the plasmon resonance wavelength shift. The binding of biomolecules
on surface induces an increase of the local RI that is proportional to the concentration of
the captured tobramycin, resulting in a redshift of the plasmon peak. The plasmon peak
extraction was performed by a custom made algorithm, which has already been validated in
dry conditions in [1].
In order to verify if our setup is able to detect small molecule binding, a tobramycin solution
10 µM in TE buffer was injected in the microfluidic channel of the L-TSPR system at 5 µl/min.
Tobramycin binding to the DNA aptamers was followed in real-time with the peak extraction
algorithm (Figure 7.1).
Despite the small molecular weight of tobramycin (467Da), a binding/dissociation curve is
clearly detectable, while the control spot (MCH) shows no apparent binding (Figure 7.1, black
lines). The signal baseline shows a standard deviation of 2.2× 10−5, that allows to clearly
distinguish the association and dissociation binding interactions.
Although the plasmonic peak extraction algorithm is able to precisely detect the peak shift in
order to follow tobramycin binding/dissociation kinetics, the long elaboration time required
(maximum of only 4 frames analyzed per second versus 8 frames per second acquired) is not
recommended in real-time measurement experiments. Furthermore, the peak extraction
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Figure 7.1: 70 µl Tobramycin 10 µM in TE 1X delivered to the DNA aptamers and to a control
MCH on surface at 5 µl/min. Peak location (black line) and hue (red line) are extracted from
the same RGB data collected by the CMOS image sensor. The red and blue vertical lines
represent the start of the association and dissociation phases, respectively. The light blue area
represents the regeneration step thanks to NaCl solution. The control spot does not show any
specific response to the injection of Tobramycin indicating that the small molecule drug is
recognized and bound to the DNA aptamer only.
algorithm is sensitive to the spatial distribution of light over the CMOS image sensor and
therefore requires a reference image as blank FTO-glass slide (with microfluidics channels
filled with running buffer) in order to normalize the RGB data.
As an alternative, hue analysis has already been used by the group of Lin [163] to detect
plasmonic changes, even though only for bulk RI measurements. The advantage of hue
calculation is that it only requires a quick conversion of the RBG values and it is therefore
possible to plot it in real-time during the experiment.
Figure 7.2: Correlation between hue shift and peak location shift in TE buffer (left) and in
serum (right).
In order to use the hue analysis for our experiments, we evaluated the correlation between the
extracted peak shift and the hue variation. First, hue analysis on the abovementioned raw data
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produces a binding/dissociation curve almost identical to the peak extraction (Figure 7.1, red
lines). Second, a linear relationship between hue value and peak location is found for different
concentrations of tobramycin and in different matrices (TE buffer and serum) (Figure 7.2).
Therefore, hue variation analysis can be safely used to measure and display in real-time the
binding of tobramycin on the surface of our T-LSPR system.
7.4 Real-time sensing of tobramycin in TE buffer
In order to confirm the ability of our gold NIs FTO-coated slides to quantify tobramycin binding
on the DNA aptamers, we sequentially injected tobramycin at different concentrations (0.5
µM, 1 µM, 2 µM, 5 µM and 10 µM, ), TE buffer and regeneration solution (1M NaCl) on the
sensing areas array via the microfluidic module at 5 µl/min (Figure 7.3).
Figure 7.3: Real-time association and dissociation of Tobramycin recognized by the selected
DNA aptamer (blue line) attached to the surface. 70 µl of tobramycin in concentrations of 0.5
µM, 1 µM, 2 µM , 5 µM and 10 µM in TE 1X are delivered to the surface at 5 µl/min. The green
line represents the control measurement performed with a layer of MCH on the NIs, which
allows to cancel out the signal of the bulk effect and to verify the occurrence of non-specific
binding. The blue and red vertical lines indicate the start of the association and dissociation
phases, respectively. The light blue areas correspond to the injection of NaCl as a regeneration
step.
The hue variation of the DNA aptamer-functionalized NIs (blue line) and of the control-
functionalized NIs (MCH, green line) was then followed in real-time. A signal proportional to
the amount of bound tobramycin is clearly visible in the aptamer-functionalized spots, while
the control spot only shows a slight variation of signal probably due to some non-specific
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binding and bulk effect. NaCl drives the baseline to its original value prior to the injection of
tobramycin, proving that tobramycin bound to the surface is removed and the DNA aptamers
are available for capturing drug molecules during the following cycle.
The importance of regeneration of the surface is fundamental in biosensing assays as it allows
of reusing the same surface without the need of re-functionalization of a new NIs FTO-coated
glass slide.
Looking at the association and dissociation phases for the different concentrations of to-
bramycin tested, Figure 7.4 shows that at 0.5 µM of tobramycin the association rate is slow
and it is evidently affected from the mass transport effect. At increasing concentrations of
tobramycin the association rate becomes faster and the saturation value is reached quicker.
Figure 7.4: Kinetics association and dissociation of tobramycin for the different concentrations
tested.
Plotting the association signal values with respect to the concentration of tobramycin injected
(Figure 7.5) allows us to fit the points using the Langmuir equation, and hence to calculate the
equilibrium binding constant, KD . KD represents the concentration of tobramycin needed to
achieve a half-maximum binding and in our case corresponds to 0.26 µM.
The same analysis performed with a commercial SPR gives a KD of 0.23 µM for the same
aptamer [47]. The high similarity of the KD obtained with our T-LSPR and the commercial
SPR indicates that the DNA aptamers are comparably functionalized on the surface, while
retaining their ability to recognize tobramycin. Moreover, this clearly shows that the T-LSPR
signal is equivalent to the commercial SPR signal for the tested concentrations.
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Figure 7.5: Hue variation for different concentrations of tobramycin averaged over 4 indepen-
dent DNA aptamer spots on the same NIs FTO glass slide (black dots) and for the MCH control
spot (red squares).
7.5 Real-time sensing of tobramycin in undiluted serum
A POC system intended to analyze patients’ blood giving a fast and precise response needs
to be able to measure tobramycin with the DNA aptamer in a more complex matrix than TE
buffer. Therefore we tested our T-LSPR set up for tobramycin detection in undiluted Fetal
Bovine Serum (FBS) as human serum surrogate. Because our system is a label-free and thus
prone to be sensitive to unspecific binding, FBS was filtered with a 3KDa cut off membrane in
order to remove most of the proteins (7.1).
Several tobramycin concentrations (10 µM, 20 µM, 40 µM, 60 µM and 80 µM) were then spiked
in filtered FBS, and injected at 10 µl/min over the sensing areas in order to be measured with
our portable T-LSPR setup (Figure 7.6).
Real-time measurements show the tobramycin detection in undiluted FBS in the DNA aptamer
spot, while the control spot shows no clear binding (data not shown). The raw data are affected
by a decreasing drift of the baseline which is compensated using the regeneration injection
signals (NaCl 1M, pure bulk) that is assumed to remain constant during the experiment.
In order to verify non-specific binding of the proteins and substances present in the serum, and
to evaluate its bulk effect, tobramycin injections were alternated with FBS without tobramycin.
Because of the higher RI of serum with respect to TE buffer, the control injections show a
pronounced bulk effect (Figure 7.6). When tobramycin is delivered to the surface (blue vertical
lines), the binding association is not evident because it is masked by the serum bulk effect.
Nevertheless, the tobramycin captured by the DNA aptamer is visible and measurable from the
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Figure 7.6: Real-time association and dissociation of tobramycin recognized by the selected
DNA aptamer attached to the surface. 70 µl of tobramycin in the concentrations of 10 µM, 20
µM, 40 µM, 60 µM and 80 µM in undiluted serum, alternated with control injections serum
without tobramycin, are delivered to the surface at 10 µl/min. The black and red vertical lines
indicate the start of the association and dissociation phases, respectively. The light blue areas
correspond to the injection of NaCl as a regeneration step.
start of the dissociation phase (red vertical lines), when TE buffer is injected in the channels
removing the serum bulk effect. The tobramycin signal exhibit a sharp increase to a value
proportional to the amount of Tobramycin injected, from which the dissociation phase begins.
Why is the serum totally masking the binding of tobramycin to the DNA aptamers? It does
not seem to be a matter of noise, as tobramycin injection at 80 µM gives a smaller signal than
its subsequent dissociation. We wondered if the serum could absorb light in the wavelengths
needed for plasmon generation. FBS absorbance spectrum measured with a commercial
spectrophotometer (Nanodrop 2000c Thermo Scientific) only shows peaks at 200 nm and 300
nm (data not shown), which is out of the range of the NIs plasmon and therefore cannot be
the cause of the masking effect.
Another possible explanation could come from the literature. The group of Vöros [164] shows
the effect of charges on plasmonics combined with electrochemistry detection. We wondered
what the electrical behavior of the small particles in serum is. A paper from the group of
Szoka [165] reports the electrical properties of molecules in solutions and how the presence of
serum alters their charge. It is possible that proteins, hormones and other molecules present
in serum have a strong impact on the dielectric environment surrounding the NIs, causing a
damping of the plasmon and reducing its penetration depth into the dielectric. However, this
hypothesis needs further investigation.
For the DNA aptamers spots, a linear trend with a sensitivity of 0.0123 (hue variation per µM) is
observed for the increasing concentrations of Tobramycin (Figure 7.7). In order to evaluate the
detection resolution for tobramycin in undiluted serum, we calculated the standard deviation
of the measured signal among 4 different aptamer spots for all the concentrations. The signal
corresponding to twice the average standard deviation indicates that the theoretical minimum
resolvable concentration of tobramycin is 3.4 µM.
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Figure 7.7: Hue variation for different concentrations of tobramycin averaged over 2 indepen-
dent DNA Aptamer spots on the same NIs FTO glass slide normalized over NaCl injections.
Nevertheless, the binding/dissociation curve at the lowest concentration of tobramycin shows
a lower signal to noise ratio which, with the present system configuration, probably will hinder
the detection at lower concentrations of tobramycin.
Currently measured concentrations of tobramycin in patients’ blood range between 1 µM
and 80 µM (Prof. Thierry Buclin, University Hospital of Lausanne, personal communication),
which is less than one order of magnitude below our minimum detectable concentration.
In fact, one big component of the noise comes from the bit noise of CMOS image sensor,
that can be reduced with a more stable power supply (that is, battery). Additionally, we can
increase the overall signal by increasing the light source intensity, therefore further increasing
the signal to noise ratio.
On the other hand, the capability of our T-LSPR sensor to resolve small RI changes is mainly
limited by the NIs FTO-glass sensor. More regular structures and patterns have been reported
to increase the sensitivity (see Section 3.2). In fact, the irregularity in size and pattern of the
NIs, together with the irregular shape of the FTO layer on glass, contribute to increase the
surface roughness and broaden the plasmon, thus reducing its sensitivity. Nevertheless, the
stability over time of these NIs and their resistance to high ionic strength solutions, critical in
biosensing [161, 117], allows to perform long time measurements and surface regeneration.
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This thesis is a multidisciplinary work that combines the technical design and implementation
of a portable label-free detection system with the use of DNA aptamers to recognize small
molecules in undiluted serum.
The attention on T-LSPR was motivated by the possibility to scale down the detection system
and to employ low-cost available components. The system is T-LSPR-based and made of off-
the-shelf components, LEDs, and CMOS image sensor, which make it compact and suitable as
a POC.
Because of the high sensitivity of the CMOS sensor in the visible range, a suitable biosensor
exhibiting LSPR in the visible spectrum was chosen. The non-connected patterns are extremely
flexible in that the plasmon resonance can be tuned by modifying the material, size, and shape
of the nanostructures. The two major constraints in the choice of the gold NIs were the
material and the stability of the nanostructures in solvents. Gold represents the most-used
material in biosensing, as it is inert and easy to functionalize via thiols. The employed NIs on
FTO-covered glass showed very high stability in solvents and in high ionic strength solutions
and proved to be suitable for surface modification and in-flow experiments.
The goal was to probe the performance of the detection principle with low-molecular-mass
molecules; for this, a direct assay, label-free configuration was chosen. In addition, such
conditions required almost no manipulation of the sample. For assay performed in TE buffer,
concentrations of tobramycin down to 0.5 µM were measured and the real-time kinetics of the
binding was extracted. The calculated KD matched the results obtained with a high-end SPR
system.
Motivated by the results obtained in saline buffer, the recognition of tobramycin by the DNA
aptamer was tested in undiluted serum. The presence of a complex matrix is known to be
the cause of several interfering signals, such as non-specific binding on the sensor surface,
concentration-dependent effects, and bulk effects. Particularly in label-free assays, the serum
would severely diminish the performance in terms of limit of detection. However, the detection
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of 10µM concentration of tobramycin was possible with our portable T-LSPR setup and, more
importantly, the sensing nanopattern demonstrated excellent stability and regenerability in
such a matrix.
Although the serum masks the binding association of tobramycin, the information of the cap-
tured tobramycin is visible and measurable from the start of the dissociation phase and leads
to a linear calibration curve. The complete masking of the association phase by the presence
of serum is not reported elsewhere, and the physical effect responsible of the hindering is still
subject to discussion. In fact, the same experiment on the high-end SPR system could not be
performed, as the output signal was not readable. Whether this is a matter of detection system
or if the type of biosensor (NIs vs planar gold layer) remains to be investigated, as 20% diluted
serum was not yet detectable in the standard SPR system.
In the portable T-LSPR setup, tobramycin detection in serum was possible because of the NIs
FTO-coated glass slides that make it possible to regenerate their surface and allow repeated
serum injection/NaCl regeneration cycles in continuous flow (up to 20 hours continuous
monitoring tested) without losing their sensing capabilities or degrading the recognition
properties of the DNA aptamer bound to their surface.
Because of the discrete nature of the exciting light and detector, a custom-made algorithm for
the reconstruction of the plasmon resonance and the identification of its peak location has
been developed. The setup and the algorithm were first validated in dry conditions on single-
stranded DNA-modified NIs. However, the algorithm applied to the real-time monitoring of
the plasmonic shift of binding events was too slow. Therefore, hue was studied as a substitutive
parameter and improved the speed of elaboration by a factor of four.
Currently, the major limitation in the measurements is represented by the low signal-to-noise
ratio of the CMOS image sensor output signal, which leads to an overall noisy hue. One
major component of the noise comes from the bit noise of the CMOS image sensor, which
can be reduced with a more stable power supply (that is, a battery). Additionally, we can
increase the overall signal by increasing the light source intensity, thereby further increasing
the signal-to-noise ratio.
On the other hand, the capability of our T-LSPR sensor to resolve small RI changes is mainly
limited by the NIs FTO-glass sensor. More regular structures and patterns can increase the
sensitivity, as the irregular size and pattern of the NIs, together with the irregular shape of the
FTO layer on glass, help increase the surface roughness and broaden the plasmon, thereby
reducing the overall sensitivity. Nevertheless, the possibility of exploring new more sensitive
structures is not excluded, as long as they guarantee high stability to solvents and a simple and
cost-effective fabrication process, with the potential for one-step surface functionalization.
POCs are rapidly growing in popularity because of the numerous advantages they offer com-
pared to conventional systems, such as the possibility for personalized medicine and in situ
diagnostics. The presented T-LSPR system still requires further optimization in order to fully
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work as a POC. At present, the delivery of reagents to surface is controlled by syringe pumps
placed externally to the case of the POC. The possibility of including small automatic piezo-
electric pumps inside the POC has been considered, although the flow-rate employed for the
presented measurements, 10 µl/min, is too low to be controlled with the commercial piezo-
electric pumps explored so far, as the fluid is pushed in gradual steps instead of continuous
flow.
In addition, the possibility of increasing the flow-rate for delivery of reagents to surface is also
considered. From one side, the mass transport effect visible at low concentrations could be
improved, but on the other side the dead volume in the tubing system will lead to a higher
consumption of reagents, as experimented in a preliminary test not shown here.
The NIs FTO-coated glass slide can host multiple spots of the DNA aptamer, allowing for
parallel monitoring of the different sites during the same measurement. The maximum
throughput reachable in the sensor was not exploited in the present study; instead, the focus
was on the real-time observation and quantification of tobramycin in serum.
Implementation of multiple arrays detection, together with the compact dimensions of the
system, allowed by the usage of low-power components, makes our device fitting the require-
ments for a POC. In conclusion, this is the first work reporting on a portable T-LSPR system
that is able to measure small molecules in undiluted serum via label-free direct assay. We are
currently approximately one order of magnitude above the minimum concentration, but it is
not too optimistic to envision that our portable T-LSPR system will soon be able to measure
through the whole clinical range.
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